rfhg_235300.1

Basic information about the TSS

---

TSS ID: rfhg_235300.1 Species: human Chr: chrX		Start: 40735691 End: 40735699 Strand: -
Source datasets	FANTOM5
Protocol	CAGE
TSS cluster detected*	1

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	pELS,CTCF-bound (EH38D4277673,EH38E2751113)
Category:	pELS

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: AK293070:-31 GeneID: 9282 HGNC/MGI_ID: HGNC:2370 UniProt_ID: A8KAK5 Nearer transcript ids and distances: BC098377:139 ENST00000324817.6:149 NM_004229.4:149 ENST00000482034.5:-159 AB006651:160 AF304448:160 BC132672:170 BC132674:170 BC144231:170 AK308871:-185 AF135802:206 AB590907:275 AF104256:279 ENST00000495865.1:393 HG518165:437 view more...

Gene_name: mediator complex subunit 14 Gene_symbol: MED14 Gene_synonyms: CRSP150 CSRP EXLM1 RGR1 TRAP170 Gene_source: HGNC:2370

TATA-Box annotation

---

Distance to TSS:	-153
Nearest PromoterID:	NM_004229
Entrez ID:	9282
Nearest Unigene:	Hs.407604
Nearest Refseq:	NM_004229
Nearest Ensembl:	ENSG00000180182
Gene Name:	mediator complex subunit 14
Gene Alias:	CRSP150|CRSP2|CSRP|CXorf4|DRIP150|EXLM1|RGR1|TRAP170
Gene Type:	protein-coding
CpG%:	0.000000
GC%:	0.555556
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@MED14 p2@MED14 p3@MED14 p4@MED14 p5@MED14 p6@MED14 p8@MED14 p9@MED14
Sample		p1@MED14	p2@MED14	p3@MED14	p4@MED14	p5@MED14	p6@MED14	p8@MED14	p9@MED14
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	24.74	10.71	11.30	7.79	0.97	5.65	1.17	2.34
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	21.85	8.30	10.52	9.71	0.61	2.43	0.40	1.82
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	26.23	11.00	14.85	5.59	0.39	3.67	0.96	1.16
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	23.70	10.40	8.94	6.03	0.42	3.53	1.66	1.87
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	22.27	7.20	11.47	5.17	0.45	4.72	0.67	2.25
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	25.97	8.72	10.47	4.26	0.58	6.40	0.58	1.74
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	31.38	10.02	14.82	7.41	1.09	5.45	1.53	0.44
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	31.25	8.72	12.35	5.81	0.00	3.15	1.21	2.91
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	28.00	9.40	12.82	5.98	0.43	3.21	0.21	2.14
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	37.68	12.75	15.07	6.38	0.58	4.06	1.16	1.16
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	25.47	7.28	14.96	5.26	0.81	1.21	0.00	1.21
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	27.65	7.32	14.64	5.69	0.81	3.25	0.81	2.85
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	26.92	4.03	2.10	2.42	0.00	0.00	0.16	0.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	25.71	2.26	0.90	0.75	0.15	0.60	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	25.47	3.95	1.54	0.88	0.44	0.22	0.22	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	24.65	3.02	2.01	0.75	0.00	0.25	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	22.28	2.62	3.28	1.75	0.44	0.44	0.00	0.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	29.11	3.80	1.69	0.84	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	23.99	4.27	2.67	1.07	0.00	0.53	0.53	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	24.22	3.61	1.50	1.81	0.00	0.60	0.00	0.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	27.13	3.47	2.14	1.87	0.00	0.13	0.13	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	23.48	2.76	1.90	1.55	0.35	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	23.01	2.71	0.90	1.03	0.13	0.00	0.26	0.13
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	19.17	4.61	1.94	0.97	0.24	0.00	0.24	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	22.96	2.32	1.81	0.77	0.00	0.77	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	22.47	2.22	1.90	1.90	0.32	0.63	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	30.22	2.20	2.75	1.10	0.55	0.00	0.00	0.55
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	26.17	2.83	1.89	2.36	0.47	0.47	0.24	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	21.64	5.81	1.78	1.62	0.16	0.65	0.32	0.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	19.54	2.53	1.63	1.63	0.00	1.27	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	22.61	2.30	1.67	2.30	0.00	0.63	0.00	0.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	23.06	3.52	1.17	1.76	0.39	0.98	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	26.38	3.59	2.32	2.74	0.42	0.84	0.42	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	24.41	2.47	1.65	2.97	0.16	0.00	0.16	0.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	23.37	3.37	1.50	2.99	0.56	1.50	0.00	0.19
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	21.46	4.60	2.49	2.11	0.19	0.96	0.96	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	17.58	3.47	1.43	1.84	0.20	1.02	0.61	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	20.75	4.43	3.63	1.81	0.00	1.81	0.20	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	14.05	4.05	2.16	2.97	0.27	0.54	0.27	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	14.88	2.88	2.16	1.44	0.48	0.48	0.48	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	18.11	2.82	1.41	1.65	0.47	0.94	0.94	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	21.37	4.10	2.20	1.46	0.00	0.88	0.44	0.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	22.14	4.43	1.90	4.01	0.21	2.53	0.63	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	21.50	4.37	2.80	3.67	0.00	0.35	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	21.68	5.42	1.81	3.21	0.60	1.41	0.20	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	24.43	4.89	2.79	3.02	0.23	0.70	0.70	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	22.79	4.08	2.16	4.56	0.48	1.20	0.24	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	28.91	3.58	1.79	3.28	0.30	0.60	0.30	0.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	25.61	5.74	1.68	4.07	0.24	1.20	0.72	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	28.11	3.84	1.62	4.25	0.40	1.42	0.20	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	34.43	5.94	3.07	5.53	0.20	1.64	0.41	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	38.25	8.23	2.00	6.00	0.44	1.78	0.67	0.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	111.94	27.98	13.99	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	25.90	6.39	1.77	4.97	0.35	1.06	0.71	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	24.85	8.95	1.33	2.32	0.00	0.99	0.33	0.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	62.92	10.07	2.52	13.42	0.00	0.84	0.84	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	42.71	8.73	1.84	6.89	1.84	1.38	0.46	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	25.93	7.78	2.92	4.54	0.32	0.97	0.65	0.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	26.66	3.85	3.85	2.57	0.32	1.93	0.96	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	48.72	9.43	2.20	6.92	0.63	0.63	1.26	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	31.02	7.76	0.71	2.12	0.00	2.82	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	20.75	10.09	4.49	3.36	0.00	0.00	0.56	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	76.43	17.52	3.98	7.17	0.80	1.59	0.80	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	51.98	13.25	1.70	4.42	1.70	1.70	0.68	0.34
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	41.91	10.72	3.90	9.10	0.65	1.95	0.65	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	29.11	11.36	1.77	3.19	0.71	3.19	1.06	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	32.33	32.33	16.16	16.16	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	78.97	15.79	7.90	15.79	0.00	7.90	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	22.43	8.29	4.39	2.44	0.49	2.44	0.00	0.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	19.83	11.41	4.96	3.47	0.50	1.49	0.00	0.50
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	25.33	7.97	2.81	6.10	0.94	0.47	0.00	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	37.09	9.94	2.32	4.64	0.00	1.99	0.66	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	24.13	8.35	1.24	6.50	0.62	3.09	0.00	0.62
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	26.60	9.48	3.06	5.20	0.61	2.14	1.22	0.31
Adipocyte - breast, donor1	11376-118A8	13.30	5.23	0.48	1.11	0.48	0.00	0.32	0.00
Adipocyte - breast, donor2	11327-117E4	11.71	4.49	0.64	0.96	0.00	0.48	0.00	0.16
Adipocyte - omental, donor1	11473-119C6	17.68	4.83	1.02	0.76	0.13	0.25	0.25	0.00
Adipocyte - omental, donor2	11474-119C7	10.46	1.49	0.75	0.75	0.00	0.00	0.00	0.00
Adipocyte - omental, donor3	11475-119C8	10.72	2.01	1.00	0.00	0.00	0.33	0.00	0.00
Adipocyte - perirenal, donor1	11476-119C9	9.57	3.19	0.00	0.64	0.00	0.00	0.00	0.00
Adipocyte - subcutaneous, donor1	11259-116F8	4.40	1.10	0.00	1.10	0.00	0.00	0.00	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	6.77	2.26	0.90	0.00	0.00	0.45	0.00	0.00
Adipocyte - subcutaneous, donor3	11408-118E4	5.91	0.87	0.17	0.00	0.00	0.00	0.00	0.00
Adipocyte differentiation, day04, donor1	13019-139D4	14.67	6.85	0.98	0.20	0.39	0.39	0.39	0.00
Adipocyte differentiation, day04, donor2	13022-139D7	12.10	5.15	0.51	0.26	0.00	0.00	0.00	0.00
Adipocyte differentiation, day04, donor3	13025-139E1	14.22	5.02	0.84	0.28	0.00	0.00	0.28	0.00
Adipocyte differentiation, day04, donor4	13028-139E4	17.63	5.29	0.00	0.59	0.00	0.00	0.00	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	15.60	4.67	0.32	0.56	0.16	0.00	0.16	0.00
Adipocyte differentiation, day08, donor2	13023-139D8	15.81	3.55	0.00	0.65	0.00	0.00	0.32	0.00
Adipocyte differentiation, day08, donor3	13026-139E2	5.87	5.33	0.53	0.00	0.00	0.00	0.00	0.00
Adipocyte differentiation, day08, donor4	13029-139E5	13.35	3.34	0.56	0.56	0.00	0.00	0.00	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	9.57	1.66	1.66	0.42	0.00	0.00	0.00	0.00
Adipocyte differentiation, day12, donor2	13024-139D9	10.55	2.51	0.25	0.75	0.50	0.25	0.00	0.00
Adipocyte differentiation, day12, donor3	13027-139E3	10.14	3.60	0.00	0.98	0.00	0.00	0.00	0.00
Adipocyte differentiation, day12, donor4	13030-139E6	9.13	1.22	0.30	0.00	0.30	0.00	0.00	0.00
Alveolar Epithelial Cells, donor1	11510-119G7	6.19	2.43	1.77	0.88	0.00	0.22	0.00	0.00
Alveolar Epithelial Cells, donor2	11590-120G6	2.87	0.36	0.36	0.00	0.00	0.36	0.00	0.00
Alveolar Epithelial Cells, donor3	11671-122G6	1.20	3.59	0.00	0.00	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	7.38	2.52	3.06	0.54	0.00	0.00	0.00	0.36
Amniotic Epithelial Cells, donor2	11613-122A2	0.00	0.00	5.02	0.00	1.67	0.00	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	4.93	1.85	2.26	0.21	0.00	0.00	0.00	0.00
Anulus Pulposus Cell, donor1	11248-116E6	8.81	4.46	0.57	0.46	0.00	0.00	0.11	0.00
Anulus Pulposus Cell, donor2	11463-119B5	6.12	4.41	0.49	0.49	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	6.74	3.15	2.25	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	8.68	3.04	0.43	0.00	0.00	0.87	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	6.42	2.14	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	4.48	2.99	0.60	0.30	0.00	0.30	0.00	0.30
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	6.32	1.26	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	7.26	1.98	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	6.82	2.92	0.65	0.32	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	6.80	1.46	0.97	1.46	0.00	0.00	0.49	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	5.34	2.38	0.00	1.19	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	6.03	3.01	2.26	0.75	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	7.98	1.45	2.90	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	7.52	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	6.92	2.31	0.99	0.66	0.16	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	8.19	1.36	0.00	1.36	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	5.13	3.02	0.90	0.45	0.00	0.15	0.00	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	4.29	1.61	0.54	1.61	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	7.56	4.16	1.32	0.38	0.00	0.38	0.19	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	5.88	3.74	2.41	0.53	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	11.71	1.95	1.95	0.98	0.00	0.98	0.98	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	4.81	4.15	1.00	0.33	0.00	0.17	0.17	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	7.20	1.20	2.40	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	14.16	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	7.72	2.92	1.54	0.34	0.34	0.00	0.69	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	4.19	4.19	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	7.28	2.43	0.97	0.49	0.49	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	7.21	4.17	0.38	1.52	0.00	0.38	0.38	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	4.85	3.63	1.21	1.21	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	7.98	3.99	0.57	1.14	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	6.20	4.06	1.50	0.64	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	6.45	2.06	0.52	0.52	0.26	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	8.45	2.35	0.00	0.94	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	4.50	2.25	0.64	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	7.13	1.43	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	7.02	2.34	1.17	0.58	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	3.91	3.01	1.20	0.30	0.00	0.00	0.30	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	5.94	1.19	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	12.71	2.54	0.51	0.51	0.51	0.00	0.51	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	7.90	3.31	1.27	0.51	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	8.90	1.27	0.64	1.91	0.64	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	6.04	3.02	0.43	0.86	0.43	0.43	0.43	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	7.20	2.75	1.27	0.42	0.00	0.21	0.00	0.21
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	4.64	2.03	0.29	0.29	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	5.67	1.89	0.94	0.00	0.00	0.00	0.94	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	6.95	2.20	0.85	0.34	0.17	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	4.63	0.00	0.00	2.32	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	10.56	2.11	2.11	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	7.72	2.57	0.64	0.64	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	3.61	3.61	1.80	1.20	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	8.02	0.00	2.19	0.73	0.73	0.00	0.73	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	5.75	2.07	0.23	0.46	0.23	0.46	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	2.55	5.10	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	4.32	1.53	0.51	0.76	0.25	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	8.05	2.89	1.45	1.65	0.00	0.21	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	5.51	1.22	0.92	0.31	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	4.30	2.39	1.91	0.00	0.48	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	6.65	2.88	0.89	0.44	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	3.05	1.53	0.00	3.05	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	4.43	1.11	0.55	1.11	0.00	0.00	0.55	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	5.83	2.65	0.53	0.00	0.53	0.26	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	6.18	0.36	0.36	0.36	0.36	0.00	0.00	0.00
Astrocyte - cerebellum, donor1	11500-119F6	12.28	4.79	1.47	0.86	0.00	0.12	0.12	0.00
Astrocyte - cerebellum, donor2	11580-120F5	7.70	3.25	1.54	0.51	0.51	0.17	0.00	0.00
Astrocyte - cerebellum, donor3	11661-122F5	5.45	3.15	0.84	0.00	0.42	0.00	0.00	0.00
Astrocyte - cerebral cortex, donor1	11235-116D2	30.68	9.06	3.49	3.83	0.35	0.35	0.35	0.00
Astrocyte - cerebral cortex, donor2	11316-117D2	25.88	14.40	2.59	2.75	0.65	0.65	1.13	0.00
Astrocyte - cerebral cortex, donor3	11392-118C6	25.51	11.19	1.64	2.09	0.75	0.45	1.04	0.15
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	28.44	26.38	17.89	8.49	3.78	2.75	0.46	1.03
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	30.57	28.94	20.67	7.64	3.63	4.76	1.38	1.00
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	30.27	27.88	20.82	7.28	3.07	2.62	0.23	0.46
Basophils, donor1	12241-129G9	17.52	8.63	1.83	1.31	4.45	0.26	1.05	0.52
Basophils, donor2	12242-129H1	15.87	19.48	3.25	2.16	4.69	0.00	0.36	0.00
Basophils, donor3	12243-129H2	15.14	9.26	1.03	0.15	2.65	0.00	0.59	0.29
Bronchial Epithelial Cell, donor1	11511-119G8	4.96	0.43	1.94	0.65	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor2	11591-120G7	2.29	0.91	1.37	0.46	0.00	0.46	0.00	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	14.35	0.00	7.17	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	3.77	0.63	2.51	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	7.69	2.50	3.95	0.83	0.42	0.00	0.00	0.21
Bronchial Epithelial Cell, donor6	11461-119B3	7.60	0.92	3.22	0.46	0.00	0.46	0.00	0.00
Bronchial Epithelial Cell, donor7	11769-123I5	9.36	0.54	3.24	1.80	0.00	0.54	0.00	0.00
Burkitt's lymphoma cell line:DAUDI	10422-106C8	25.87	16.08	6.70	2.47	1.24	0.62	0.10	0.72
Burkitt's lymphoma cell line:RAJI	10476-106I8	22.59	12.34	8.38	2.56	0.47	0.00	0.47	0.00
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	8.95	15.67	0.64	1.92	2.56	0.00	0.00	0.00
CD133+ stem cells - cord blood derived, pool1	12223-129E9	10.34	20.68	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	15.78	9.58	2.25	0.56	1.13	0.00	1.13	0.56
CD14+ Monocytes, donor2	11305-117B9	21.34	8.54	0.93	0.74	1.48	0.00	0.19	0.19
CD14+ Monocytes, donor3	11381-118B4	13.83	7.90	0.88	0.44	2.20	0.00	0.22	0.22
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	16.70	7.08	1.70	0.28	0.57	0.00	0.00	0.00
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	26.54	7.20	1.90	0.76	0.76	0.00	0.00	0.00
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	23.01	5.92	0.66	0.00	0.00	0.00	0.66	0.00
CD14+ monocytes - mock treated, donor1	11863-125A9	28.48	8.67	0.87	1.59	1.59	0.29	0.00	0.14
CD14+ monocytes - mock treated, donor2	11873-125C1	28.67	8.15	0.60	3.02	3.02	0.60	0.00	0.00
CD14+ monocytes - mock treated, donor3	11883-125D2	26.30	15.16	3.55	2.13	5.92	0.47	0.47	0.24
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	29.29	7.20	1.34	1.51	1.34	0.17	0.00	0.17
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	21.25	9.38	1.93	2.21	3.86	0.28	0.55	0.83
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	31.24	15.87	0.99	3.47	3.22	2.48	0.50	1.24
CD14+ monocytes - treated with BCG, donor1	11860-125A6	22.13	4.70	0.78	0.78	1.17	0.39	0.00	0.00
CD14+ monocytes - treated with BCG, donor2	11870-125B7	18.52	6.05	1.25	0.53	1.96	0.18	0.18	0.53
CD14+ monocytes - treated with BCG, donor3	11880-125C8	24.59	7.83	1.52	2.18	1.74	1.52	1.09	0.44
CD14+ monocytes - treated with Candida, donor1	11868-125B5	23.88	6.09	1.87	2.81	1.40	0.47	0.00	0.00
CD14+ monocytes - treated with Candida, donor2	11878-125C6	31.68	12.14	1.06	5.28	3.70	1.58	1.06	1.06
CD14+ monocytes - treated with Candida, donor3	11888-125D7	24.41	12.20	3.33	3.33	1.11	0.00	1.11	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	26.33	6.10	1.93	1.93	0.30	0.00	0.15	0.30
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	26.34	13.17	1.60	2.39	2.20	0.40	0.60	0.80
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	21.44	12.70	1.87	2.08	4.58	1.04	1.25	0.62
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	31.34	7.78	0.92	1.14	2.06	0.46	0.23	0.00
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	30.99	15.83	2.49	4.30	5.88	0.45	0.68	0.68
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	21.82	12.66	1.31	3.06	2.62	0.44	0.44	0.87
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	30.13	4.57	0.27	1.61	0.81	0.54	0.00	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	25.82	8.03	2.09	1.74	1.92	0.35	0.35	0.17
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	21.88	8.00	2.10	1.26	2.52	0.42	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	28.11	6.06	0.92	1.10	0.55	0.18	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	33.47	8.10	2.11	3.52	1.41	0.70	1.06	0.00
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	28.52	10.09	1.75	5.70	2.19	1.75	2.19	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	28.07	5.23	1.22	2.09	1.74	0.70	0.35	0.17
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	22.30	6.32	1.12	0.74	1.49	0.74	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	28.24	10.13	2.16	4.74	1.94	1.72	0.65	0.22
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	25.39	3.69	1.23	1.23	0.82	0.00	0.00	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	33.84	8.58	2.78	3.94	3.48	0.46	0.23	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	25.06	7.19	2.55	0.93	1.62	0.70	0.23	0.23
CD14+CD16+ Monocytes, donor1	11789-124B7	15.91	5.01	0.22	0.87	0.44	0.22	0.00	0.00
CD14+CD16+ Monocytes, donor2	11801-124D1	18.48	5.08	0.92	0.23	0.92	0.00	0.00	0.00
CD14+CD16+ Monocytes, donor3	11912-125G4	15.81	3.03	0.65	0.87	0.00	0.00	0.00	0.00
CD14+CD16- Monocytes, donor1	11788-124B6	34.10	2.65	0.62	1.09	0.31	0.16	0.31	0.16
CD14+CD16- Monocytes, donor2	11799-124C8	22.18	5.41	0.70	0.00	0.00	0.00	0.17	0.00
CD14+CD16- Monocytes, donor3	11910-125G2	36.34	6.69	0.45	0.67	0.67	0.22	0.22	0.00
CD14-CD16+ Monocytes, donor1	11790-124B8	22.71	3.57	2.55	1.53	0.26	0.26	0.26	0.00
CD14-CD16+ Monocytes, donor2	11800-124C9	20.42	4.61	1.76	1.32	0.22	0.22	0.22	0.00
CD14-CD16+ Monocytes, donor3	11911-125G3	19.16	2.95	0.21	0.63	0.42	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	36.58	20.32	6.10	6.10	2.03	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	18.98	19.66	5.42	0.68	2.03	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	20.71	20.71	8.28	4.14	0.00	0.00	1.04	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	20.26	22.92	9.59	2.13	2.13	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	18.23	16.08	8.58	0.00	0.54	0.00	0.54	0.00
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	26.67	19.65	7.02	1.40	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	24.31	16.47	10.20	1.57	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	15.82	17.14	7.91	2.64	1.32	0.00	0.00	0.00
CD19+ B Cells, donor1	11544-120B5	32.88	15.62	11.51	8.22	4.11	1.64	0.00	0.00
CD19+ B Cells, donor2	11624-122B4	31.92	30.47	9.43	2.18	2.18	0.73	0.00	2.18
CD19+ B Cells, donor3	11705-123B4	22.72	14.14	10.60	2.02	3.03	2.02	0.50	0.50
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	32.32	2.83	3.23	5.25	0.00	1.21	0.00	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	12.38	1.20	2.80	4.39	0.00	0.00	0.00	0.00
CD34+ Progenitors, donor1	11545-120B6	16.06	17.07	0.00	2.01	9.04	0.00	0.00	1.00
CD34+ Progenitors, donor2	11625-122B5	15.73	26.40	2.81	0.56	24.72	0.00	0.56	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	15.78	14.28	1.88	1.13	1.88	0.00	0.00	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	17.36	16.23	2.25	0.90	2.71	0.00	0.23	0.00
CD4+ T Cells, donor1	11225-116C1	23.92	26.78	20.35	3.93	3.57	1.07	1.43	5.71
CD4+ T Cells, donor2	11306-117C1	23.88	24.49	15.31	7.35	6.74	1.84	2.45	3.06
CD4+ T Cells, donor3	11382-118B5	21.96	20.13	7.01	3.35	7.32	1.22	3.05	4.57
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	16.34	14.55	7.91	2.81	0.51	0.26	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	14.37	14.60	6.96	3.14	1.12	0.90	0.22	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	13.22	11.50	9.49	2.30	0.29	0.86	0.00	0.29
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	12.33	24.18	24.18	1.90	2.84	0.47	1.90	1.42
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	17.56	9.83	12.64	3.51	1.40	0.00	0.70	2.11
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	13.18	6.59	9.89	9.89	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	17.63	7.95	4.48	2.46	0.58	0.14	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	14.57	10.34	4.24	1.36	1.19	0.68	0.17	0.34
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	12.41	8.06	3.39	3.22	0.32	0.48	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	13.00	8.97	6.28	3.14	1.79	0.90	0.00	0.90
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	17.82	5.94	6.64	3.14	0.70	0.35	0.00	0.70
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	20.68	12.32	8.36	3.08	3.08	1.76	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	21.50	9.28	6.75	5.06	1.26	0.00	0.42	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	12.67	9.56	5.82	3.12	0.21	0.62	0.21	0.42
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	11.69	9.36	4.34	1.67	1.00	0.00	0.00	0.67
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	29.64	15.23	18.76	6.53	0.27	1.09	1.90	2.18
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	35.37	15.54	22.51	7.50	0.54	1.07	1.07	1.07
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	16.14	12.55	10.76	16.14	0.00	0.00	0.00	5.38
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	24.66	10.01	6.68	3.71	1.30	0.37	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	18.63	9.75	3.90	2.17	0.43	0.43	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	17.44	8.62	3.15	3.15	1.05	0.63	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	18.20	13.65	12.64	7.08	1.52	0.00	1.52	4.04
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	20.36	7.80	6.50	4.33	1.30	0.00	0.43	0.87
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	25.71	10.90	9.59	5.67	1.31	0.44	0.00	3.49
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	19.79	9.90	13.36	3.96	0.49	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	24.93	16.62	6.46	0.92	1.85	0.92	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	5.58	13.96	8.37	1.40	2.79	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	22.99	14.40	8.86	2.77	2.22	0.55	0.00	0.28
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	26.99	15.46	12.27	2.70	1.72	0.00	0.00	0.25
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	29.26	20.02	12.32	7.70	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	23.28	17.19	10.39	3.22	1.79	0.72	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	19.39	16.62	11.08	1.38	1.38	1.38	0.00	0.00
CD8+ T Cells, donor1	11226-116C2	11.13	47.47	9.17	3.27	18.99	0.33	2.95	2.62
CD8+ T Cells, donor2	11307-117C2	9.76	41.67	9.01	2.25	21.78	0.75	1.13	2.25
CD8+ T Cells, donor3	11383-118B6	15.40	35.60	9.85	3.03	11.11	0.50	3.79	4.04
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	3.90	4.82	1.15	1.38	0.69	0.69	0.00	0.00
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	3.59	3.83	1.44	2.16	0.48	0.24	0.00	0.00
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	5.20	2.74	2.19	2.46	0.27	0.27	0.27	0.27
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	3.60	6.90	1.50	2.10	0.60	0.60	0.00	0.00
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	3.36	3.36	3.12	1.20	0.72	0.72	0.00	0.24
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	3.41	5.23	2.96	2.05	1.14	0.23	0.00	0.23
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	5.43	6.30	3.26	1.96	0.00	0.00	0.00	0.00
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	5.00	5.26	2.11	1.05	0.00	0.79	0.00	0.26
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	3.99	7.74	3.28	1.41	0.23	0.00	0.23	0.00
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	6.04	7.55	1.21	0.91	0.30	0.30	0.60	0.00
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	5.23	5.52	2.61	1.16	1.16	0.00	0.00	0.00
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	5.06	7.46	2.40	2.93	1.60	1.60	0.27	0.00
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	3.50	7.44	2.19	3.50	1.75	0.44	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	5.47	6.38	3.19	1.37	2.28	0.91	0.91	0.00
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	2.98	8.20	3.73	5.97	6.71	0.75	0.75	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	1.80	4.32	1.08	2.16	0.36	0.72	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	2.88	6.62	1.73	0.29	0.00	0.58	0.58	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	2.83	4.48	0.94	1.18	0.94	0.71	0.00	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	5.07	5.70	2.22	2.85	0.95	0.00	0.63	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	4.31	7.38	1.85	1.54	0.00	0.31	0.00	0.31
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	2.24	6.41	1.60	2.24	0.64	0.64	0.00	0.32
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	1.91	3.44	1.53	1.15	0.76	0.38	0.00	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	3.15	3.94	1.97	1.18	1.97	0.00	0.39	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	2.27	5.29	3.78	0.76	0.76	0.76	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	3.21	8.03	5.62	0.80	0.80	1.61	0.80	0.80
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	4.20	3.50	6.29	3.50	2.10	0.00	0.70	1.40
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	8.01	10.02	5.01	4.01	0.00	0.00	1.00	0.00
Cardiac Myocyte, donor1	11525-119I4	10.97	0.00	1.83	0.00	0.00	3.66	0.00	0.00
Cardiac Myocyte, donor2	11605-120I3	4.94	3.46	0.99	0.00	0.49	0.00	0.00	0.00
Cardiac Myocyte, donor3	11686-122I3	8.21	4.00	1.79	0.74	0.32	0.00	0.11	0.11
Chondrocyte - de diff, donor1	11261-116G1	10.75	4.51	1.04	1.04	0.35	0.00	0.35	0.00
Chondrocyte - de diff, donor2	11338-117F6	7.82	3.20	0.36	1.07	0.00	0.00	0.00	0.00
Chondrocyte - de diff, donor3	11410-118E6	8.31	2.28	0.11	0.23	0.00	0.00	0.00	0.00
Chondrocyte - re diff, donor2	11339-117F7	30.44	20.59	3.58	5.37	0.00	0.90	0.00	0.00
Chondrocyte - re diff, donor3	11411-118E7	16.58	5.26	2.83	2.43	0.00	0.81	0.40	0.00
Ciliary Epithelial Cells, donor1	11242-116D9	19.28	14.57	4.82	2.98	0.57	0.46	0.23	0.00
Ciliary Epithelial Cells, donor2	11323-117D9	9.62	9.83	3.42	1.92	0.64	1.28	0.21	0.00
Ciliary Epithelial Cells, donor3	11399-118D4	11.77	8.76	4.96	2.21	0.44	0.44	0.18	0.09
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	24.39	7.24	5.78	3.21	0.09	0.73	0.18	0.73
Corneal Epithelial Cells, donor1	11526-119I5	1.54	0.44	1.76	0.22	0.00	0.00	0.00	0.00
Corneal Epithelial Cells, donor2	11606-120I4	3.41	4.55	6.83	1.14	0.00	2.28	0.00	0.00
Corneal Epithelial Cells, donor3	11687-122I4	5.88	0.77	3.07	0.77	0.00	0.51	0.00	0.00
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	5.94	16.84	0.99	2.31	1.98	0.83	0.33	0.33
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	7.57	18.92	0.32	2.52	5.36	0.63	0.63	0.00
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	3.45	17.25	3.45	0.00	6.90	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	3.67	13.93	0.43	0.97	3.24	0.65	0.65	0.00
Dendritic Cells - plasmacytoid, donor1	11228-116C4	19.47	21.87	5.81	3.07	1.02	0.34	0.00	0.00
Dendritic Cells - plasmacytoid, donor2	11309-117C4	22.85	22.20	6.53	3.26	1.31	1.31	0.00	0.65
Dendritic Cells - plasmacytoid, donor3	11385-118B8	26.13	30.00	6.78	1.94	3.87	0.97	0.48	0.48
Endothelial Cells - Aortic, donor0	11207-116A1	8.00	6.34	1.00	0.83	0.17	0.00	0.17	0.00
Endothelial Cells - Aortic, donor1	11263-116G3	1.76	3.52	2.35	0.00	0.00	0.00	0.00	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	7.64	3.68	0.85	0.28	0.57	0.00	0.00	0.00
Endothelial Cells - Aortic, donor3	11412-118E8	10.22	4.33	0.79	0.39	0.00	0.79	0.79	0.00
Endothelial Cells - Artery, donor1	11264-116G4	13.67	4.36	1.16	0.58	0.29	0.00	0.58	0.29
Endothelial Cells - Artery, donor2	11341-117F9	13.88	9.65	2.35	0.71	2.12	0.24	0.24	0.47
Endothelial Cells - Artery, donor3	11413-118E9	10.69	5.08	0.53	0.53	1.05	0.00	0.35	0.18
Endothelial Cells - Lymphatic, donor1	11236-116D3	11.30	8.87	1.55	1.33	0.44	0.22	0.00	0.00
Endothelial Cells - Lymphatic, donor2	11317-117D3	14.00	11.26	1.22	0.61	1.22	0.30	0.00	0.61
Endothelial Cells - Lymphatic, donor3	11393-118C7	14.10	12.40	1.97	0.56	1.13	0.00	0.00	0.56
Endothelial Cells - Microvascular, donor1	11265-116G5	5.05	2.67	0.30	1.49	0.30	0.00	0.00	0.00
Endothelial Cells - Microvascular, donor2	11342-117G1	7.81	8.33	1.04	1.56	1.04	0.00	0.00	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	4.54	3.12	0.28	0.00	0.14	0.00	0.00	0.14
Endothelial Cells - Thoracic, donor1	11266-116G6	24.41	9.60	2.80	2.40	1.20	0.00	0.40	0.00
Endothelial Cells - Thoracic, donor2	11343-117G2	6.81	7.34	0.00	0.00	2.10	0.00	0.52	0.52
Endothelial Cells - Umbilical vein, donor1	11243-116E1	27.71	14.54	1.37	1.37	0.75	0.12	0.12	0.12
Endothelial Cells - Umbilical vein, donor2	11324-117E1	19.55	9.99	0.87	1.09	1.96	0.00	0.00	0.00
Endothelial Cells - Umbilical vein, donor3	11400-118D5	23.57	10.87	2.08	0.61	1.10	0.00	0.37	0.12
Endothelial Cells - Vein, donor1	11267-116G7	5.69	3.41	1.14	0.00	0.00	0.00	0.00	0.00
Endothelial Cells - Vein, donor2	11344-117G3	4.89	7.68	0.70	0.00	0.70	0.00	0.00	0.00
Endothelial Cells - Vein, donor3	11416-118F3	10.05	10.21	0.79	0.79	0.63	0.00	0.31	0.16
Eosinophils, donor1	12244-129H3	0.00	15.25	0.00	0.00	15.25	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	42.91	105.62	1.65	3.30	21.45	0.00	8.25	0.00
Eosinophils, donor3	12246-129H5	64.20	35.67	7.13	3.57	10.70	0.00	3.57	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	3.91	1.22	1.71	0.24	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor2	11587-120G3	4.16	0.00	2.08	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	0.00	16.27	0.00	0.00	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	14.37	4.52	0.82	0.41	0.00	0.00	0.00	0.00
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	4.82	0.55	0.33	0.11	0.00	0.00	0.00	0.00
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	10.29	2.49	0.22	0.98	0.11	0.22	0.00	0.00
Fibroblast - Aortic Adventitial, donor1	11245-116E3	12.13	4.85	1.21	0.61	0.24	0.00	0.12	0.36
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	16.79	3.68	1.23	1.09	0.27	0.14	0.27	0.14
Fibroblast - Aortic Adventitial, donor2	11326-117E3	9.81	2.53	1.05	0.63	0.32	0.32	0.00	0.00
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	21.08	3.43	3.43	1.58	1.05	0.00	0.26	0.00
Fibroblast - Aortic Adventitial, donor3	11401-118D6	9.63	6.31	2.66	2.66	0.66	0.33	0.33	0.00
Fibroblast - Cardiac, donor1	11268-116G8	7.26	3.18	2.27	0.91	0.00	0.00	0.00	0.00
Fibroblast - Cardiac, donor2	11345-117G4	6.06	5.31	3.79	0.76	0.00	0.76	0.00	0.00
Fibroblast - Cardiac, donor3	11417-118F4	5.84	2.84	1.26	1.10	0.00	0.16	0.32	0.16
Fibroblast - Cardiac, donor4	11452-119A3	14.85	8.18	0.00	1.21	0.91	0.61	0.30	0.30
Fibroblast - Cardiac, donor5	11456-119A7	13.07	4.95	1.78	1.02	0.13	0.00	0.00	0.00
Fibroblast - Cardiac, donor6	11460-119B2	9.55	7.12	0.91	0.30	0.76	0.30	0.00	0.00
Fibroblast - Choroid Plexus, donor1	11492-119E7	12.33	5.23	1.47	0.80	0.54	0.13	0.13	0.00
Fibroblast - Choroid Plexus, donor2	11572-120E6	8.63	3.45	0.86	0.43	0.43	0.00	0.43	0.00
Fibroblast - Choroid Plexus, donor3	11653-122E6	10.25	5.86	0.00	2.93	0.00	1.46	0.00	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	8.07	1.15	0.92	0.92	0.23	0.23	0.00	0.00
Fibroblast - Conjunctival, donor3	11692-122I9	13.06	4.24	0.85	0.34	0.00	0.00	0.17	0.00
Fibroblast - Dermal, donor1	11269-116G9	5.17	2.35	0.70	0.47	0.23	0.47	0.00	0.00
Fibroblast - Dermal, donor2	11346-117G5	6.60	3.77	0.47	0.47	0.00	0.00	0.00	0.00
Fibroblast - Dermal, donor3	11418-118F5	5.68	1.45	0.12	0.36	0.00	0.24	0.12	0.00
Fibroblast - Dermal, donor4	11450-119A1	21.59	4.63	1.02	0.45	0.00	0.23	0.11	0.00
Fibroblast - Dermal, donor5	11454-119A5	17.79	4.19	1.57	0.52	0.35	0.17	0.35	0.00
Fibroblast - Dermal, donor6	11458-119A9	21.12	6.17	1.30	0.81	0.00	0.00	0.00	0.00
Fibroblast - Gingival, donor1	11237-116D4	16.03	3.33	1.04	0.42	0.00	0.00	0.00	0.00
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	15.20	2.62	1.31	1.05	0.26	0.26	0.00	0.00
Fibroblast - Gingival, donor2	11318-117D4	12.78	4.09	1.19	0.13	0.26	0.13	0.26	0.00
Fibroblast - Gingival, donor3	11394-118C8	17.69	3.09	0.58	0.19	0.10	0.10	0.00	0.00
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	11.43	2.08	0.00	2.08	0.00	0.00	0.00	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	11.98	3.17	1.23	0.53	0.18	0.00	0.18	0.00
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	20.27	6.55	0.62	1.56	0.16	0.16	0.31	0.16
Fibroblast - Gingival, donor6 (control)	11922-125H5	16.77	6.36	0.54	0.41	0.41	0.27	0.00	0.00
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	44.11	3.88	1.76	1.41	0.00	0.35	0.35	0.00
Fibroblast - Gingival, donor7 (control)	11924-125H7	19.16	4.53	0.88	0.58	0.00	0.00	0.29	0.15
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	18.27	3.00	1.36	1.23	0.27	0.14	0.00	0.00
Fibroblast - Gingival, donor8 (control)	11926-125H9	22.49	3.29	0.77	1.65	0.22	0.22	0.22	0.00
Fibroblast - Gingival, donor9 (control)	11927-125I1	22.45	3.96	0.44	0.59	0.15	0.00	0.44	0.00
Fibroblast - Lung, donor1	11270-116H1	1.36	4.08	0.00	1.36	0.00	0.00	0.00	0.00
Fibroblast - Lung, donor2	11347-117G6	26.86	1.49	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Lung, donor3	11419-118F6	8.23	2.32	1.27	0.84	0.00	0.00	0.21	0.00
Fibroblast - Lymphatic, donor1	11506-119G3	14.99	4.17	3.33	0.00	0.00	0.00	0.00	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	2.80	1.40	1.40	1.40	0.00	0.00	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	1.96	1.12	0.28	0.28	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor1	11540-120B1	15.83	7.71	2.84	0.81	0.00	0.81	0.00	0.00
Fibroblast - Mammary, donor2	11620-122A9	7.99	3.99	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	5.96	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	20.95	4.85	0.78	0.39	0.19	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor2	11319-117D5	22.75	7.43	1.82	0.46	0.00	0.15	0.15	0.00
Fibroblast - Periodontal Ligament, donor3	11395-118C9	23.56	7.96	0.61	0.61	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	15.26	3.05	0.76	0.76	0.00	0.38	0.00	0.00
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	11.07	2.70	0.27	0.81	0.27	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	12.18	2.55	0.70	0.58	0.35	0.12	0.00	0.00
Fibroblast - Pulmonary Artery, donor1	11250-116E8	5.97	4.86	1.66	0.22	0.55	0.33	0.11	0.11
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	12.80	5.28	2.03	1.22	0.41	0.41	0.20	0.00
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	8.69	1.34	0.00	0.67	0.00	0.00	0.00	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	5.14	1.98	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	26.79	8.33	2.38	2.38	0.20	0.40	0.20	0.20
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	16.34	3.91	0.89	0.89	0.36	0.00	0.36	0.00
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	14.19	5.72	0.99	1.58	0.00	0.59	0.20	0.00
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	18.65	4.81	3.31	1.20	0.00	0.60	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	17.49	3.78	0.76	1.84	0.22	0.22	0.00	0.00
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	16.45	3.04	1.52	0.76	0.25	0.00	0.51	0.00
Fibroblast - skin normal, donor1	11553-120C5	11.98	2.63	1.48	0.98	0.33	0.16	0.16	0.00
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	25.06	12.83	4.21	2.61	0.60	0.40	0.20	0.00
Fibroblast - skin normal, donor2	11561-120D4	14.37	4.12	1.71	1.61	0.10	0.30	0.20	0.00
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	31.13	5.74	2.42	2.12	0.60	0.30	0.30	0.00
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	18.23	4.06	0.33	1.49	0.33	0.00	0.08	0.08
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	16.41	3.08	0.17	0.68	0.34	0.00	0.34	0.00
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	22.99	4.93	3.61	1.64	0.66	0.33	0.00	0.00
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	18.11	3.94	1.92	0.85	0.00	0.21	0.21	0.00
Fibroblast - skin walker warburg, donor1	11554-120C6	10.29	4.89	2.19	0.67	0.17	0.34	0.17	0.00
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	11.60	0.94	0.78	1.25	0.00	0.00	0.16	0.00
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	22.16	0.00	0.00	0.00	0.00	22.16	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	33.12	0.00	2.61	3.49	0.00	5.23	0.87	0.87
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	12.83	5.72	7.28	1.73	0.00	0.35	0.52	0.35
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	15.87	5.20	5.73	3.38	0.26	0.52	0.26	0.26
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	11.75	6.39	3.07	1.28	0.00	1.28	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	28.33	11.48	6.12	4.59	0.00	1.53	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	28.71	7.02	5.74	3.83	0.00	3.19	1.91	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	75.02	6.85	4.28	5.71	0.29	2.28	2.28	0.29
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	55.15	11.86	4.96	5.52	0.55	1.93	0.83	0.28
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	46.35	7.08	4.11	5.48	0.46	1.60	0.91	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	69.15	8.52	6.14	4.95	0.59	2.18	1.39	0.40
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	55.51	7.67	6.61	5.29	0.26	1.32	0.79	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	39.14	12.72	11.74	3.26	0.65	1.30	0.98	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	92.87	7.08	4.86	6.19	0.88	3.54	0.88	0.44
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	68.26	18.37	10.88	7.35	1.41	3.25	3.53	0.57
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	64.65	16.99	13.05	5.91	1.11	0.99	1.48	0.62
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	58.56	17.46	9.67	8.06	0.54	3.22	1.88	1.07
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	35.06	12.02	7.43	1.98	0.74	0.62	0.50	0.12
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	47.34	16.06	12.32	3.74	0.42	1.94	1.66	0.69
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	38.42	12.60	9.96	5.29	0.20	2.44	1.02	0.20
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	32.40	9.13	5.48	3.19	0.68	0.68	0.68	0.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	43.47	11.71	10.46	3.36	0.12	1.49	0.75	0.37
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	47.87	13.55	6.34	8.09	0.22	1.97	0.66	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	33.98	9.16	6.80	2.36	0.59	1.18	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	40.53	13.19	8.42	5.25	0.48	1.59	0.79	0.16
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	42.67	12.96	11.39	3.80	0.45	0.89	1.56	0.22
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	41.54	11.09	7.06	3.43	0.60	0.81	0.60	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	42.24	12.21	8.65	2.54	1.19	0.34	1.36	0.17
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	52.05	17.91	11.00	5.05	1.06	1.68	0.98	0.53
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	72.32	16.54	7.39	3.43	0.21	0.21	0.83	0.21
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	64.21	14.86	5.98	4.10	0.34	0.34	0.85	0.17
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	45.15	11.51	7.64	2.66	0.66	0.33	0.55	0.11
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	43.68	15.56	8.74	4.91	0.75	0.58	0.67	0.75
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	40.84	13.27	11.03	5.10	0.41	0.61	0.20	0.41
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	40.23	8.46	4.95	2.06	0.21	0.00	0.41	0.21
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	44.62	9.34	6.69	1.38	0.46	0.46	0.35	0.12
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	32.85	13.34	4.67	2.84	0.67	0.00	0.17	0.33
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	33.06	7.49	2.42	1.98	0.22	0.00	0.22	0.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	48.83	11.19	3.57	1.60	0.00	0.25	0.25	0.37
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	33.39	9.56	5.67	1.95	0.81	0.97	0.65	0.65
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	49.39	9.94	6.41	1.60	0.00	0.96	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	33.45	7.96	4.93	1.23	0.28	0.47	0.19	0.09
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	33.85	7.12	4.27	1.27	0.32	0.32	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	37.40	9.73	5.17	4.56	0.91	0.61	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	29.58	10.87	5.12	1.78	0.52	0.21	0.52	0.00
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	37.10	10.32	2.63	2.42	0.00	0.44	0.44	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	30.86	9.82	3.93	4.49	0.28	0.28	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	26.11	13.61	5.00	1.11	0.65	0.28	0.19	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	24.87	9.36	3.21	2.41	0.27	0.53	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	20.96	12.39	6.58	1.84	0.31	1.07	0.46	0.31
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	19.17	11.40	3.37	1.30	0.65	0.52	0.00	0.13
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	29.28	9.22	4.88	1.63	0.27	0.54	0.00	0.54
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	25.26	11.98	2.95	1.66	0.55	0.18	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	30.05	10.97	2.85	1.75	0.00	0.44	0.22	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	48.60	13.88	4.96	4.96	0.99	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	25.85	9.37	3.96	1.58	0.53	0.53	0.26	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	23.00	10.29	2.82	1.82	0.00	0.00	0.40	0.20
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	84.89	28.97	11.44	6.10	1.78	1.27	0.00	0.51
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	153.48	32.25	16.32	17.12	1.99	5.37	12.74	2.39
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	91.83	18.03	13.87	7.86	0.46	2.00	5.55	0.62
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	162.64	38.46	19.44	16.16	2.05	9.82	8.80	3.48
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	21.91	8.45	4.07	2.50	0.31	1.56	1.25	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	13.85	6.50	1.41	3.67	0.85	1.70	0.85	0.57
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	55.81	17.06	10.15	8.76	0.46	1.38	3.69	1.38
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	29.70	7.42	0.00	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	14.31	5.80	6.19	2.32	0.00	0.39	0.77	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	22.46	12.84	16.04	3.21	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	19.13	3.48	3.48	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	11.39	4.56	3.91	1.95	0.00	0.98	0.00	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	22.65	4.53	4.53	0.82	0.00	0.41	0.41	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	29.99	6.66	10.00	3.33	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	12.86	4.47	3.92	1.12	0.28	0.56	0.28	0.28
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	14.38	4.58	1.63	1.31	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	17.62	3.36	5.87	1.68	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	19.72	4.77	6.68	3.18	0.64	0.95	0.00	0.32
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	11.89	1.70	2.38	0.68	1.02	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	14.62	8.35	2.09	0.00	2.09	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	19.47	6.87	2.29	0.57	0.00	0.57	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	14.80	4.14	3.85	0.30	0.30	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	11.86	0.00	3.39	1.69	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	12.01	5.80	5.38	0.83	0.00	0.41	0.41	0.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	12.66	6.21	4.37	1.61	0.23	0.46	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	15.81	0.00	0.00	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	14.61	2.69	3.08	0.77	0.00	0.00	0.38	0.38
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	13.36	5.54	1.63	0.65	0.00	0.00	0.33	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	12.04	4.68	4.68	4.01	0.00	0.00	0.67	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	25.81	5.01	2.70	1.54	0.00	0.00	0.39	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	18.49	8.22	3.77	2.40	0.68	1.37	0.00	0.34
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	14.91	7.45	7.45	2.48	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	23.59	3.77	3.30	1.89	0.00	0.47	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	22.33	3.62	4.83	0.00	1.81	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	25.43	3.56	4.58	0.51	0.00	0.51	0.51	1.02
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	18.75	4.39	2.79	1.99	0.00	0.40	0.00	0.40
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	24.67	6.41	1.97	2.47	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	31.87	3.54	8.26	1.18	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	15.17	3.50	4.08	1.17	0.00	0.00	0.58	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	30.28	6.14	3.51	3.07	0.00	0.44	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	19.50	2.54	1.70	2.54	0.00	0.00	0.85	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	11.34	4.78	2.98	1.19	0.00	0.00	0.00	0.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	13.10	5.34	5.82	0.97	0.49	0.49	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	6.85	7.99	0.00	1.14	0.00	1.14	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	9.56	3.33	0.42	0.42	0.00	0.00	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	6.75	4.50	2.25	0.00	0.00	0.00	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	13.64	2.54	0.00	0.95	0.00	0.00	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	3.34	0.42	0.42	0.00	0.00	0.00	0.00	0.00
Hep-2 cells mock treated, biol_rep1	11898-125E8	18.33	3.71	3.95	2.09	0.23	0.70	0.00	0.35
Hep-2 cells mock treated, biol_rep2	11899-125E9	20.26	4.90	3.54	3.38	0.17	1.18	0.00	0.34
Hep-2 cells mock treated, biol_rep3	11900-125F1	14.56	3.64	2.05	1.82	0.00	2.05	0.23	0.23
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	16.07	4.04	3.61	2.40	0.44	0.98	0.11	0.11
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	17.84	4.51	3.44	1.72	0.43	0.43	0.00	0.21
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	18.73	4.09	4.95	2.37	0.00	1.08	0.00	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	16.31	3.24	2.99	1.49	0.50	0.37	0.00	0.12
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	15.44	4.29	2.92	2.40	0.17	0.34	0.17	0.17
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	16.66	1.92	2.56	1.28	0.00	0.96	0.00	0.64
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	6.72	4.48	0.00	1.68	0.56	0.00	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	7.36	2.16	0.00	0.87	0.00	0.00	0.00	0.43
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	21.15	10.58	2.64	0.00	5.29	0.00	0.00	2.64
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	6.70	2.12	0.71	0.71	0.35	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	1.45	1.45	0.00	0.00	0.00	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	4.72	4.02	2.45	0.17	0.17	0.17	0.00	0.35
Hepatocyte, donor1	11523-119I2	24.21	12.11	10.90	2.42	0.00	0.00	1.21	0.00
Hepatocyte, donor2	11603-120I1	23.70	5.39	6.46	2.15	2.15	2.15	0.00	0.00
Hepatocyte, donor3	11684-122I1	21.47	4.29	6.75	4.29	0.00	0.61	0.61	0.00
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	20.89	28.72	12.40	1.31	1.31	0.65	1.31	0.00
Intestinal epithelial cells (polarized), donor1	11246-116E4	27.44	3.85	7.34	3.85	0.52	1.22	0.52	0.35
Iris Pigment Epithelial Cells, donor1	11530-119I9	8.78	3.98	1.65	1.10	0.00	0.14	0.27	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	25.47	0.00	3.18	6.37	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	6.68	0.00	0.00	6.68	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	108.33	0.00	27.08	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	12.46	2.77	8.31	1.38	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	7.51	0.00	2.50	2.50	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	11.87	11.87	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	7.69	0.00	2.56	2.56	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	0.00	0.00	13.71	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	11.37	1.62	11.37	1.62	0.00	0.00	0.00	1.62
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	6.67	0.00	6.67	5.00	0.00	5.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	10.89	0.00	10.89	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	17.21	6.62	10.59	1.32	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	7.76	2.22	3.33	3.33	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	5.24	0.00	10.48	5.24	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	10.71	2.52	6.30	2.52	0.63	0.63	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	6.19	1.55	6.19	3.09	0.00	1.55	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	0.00	0.00	14.63	0.00	0.00	14.63	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	14.86	2.58	6.46	3.88	0.00	0.65	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	12.88	6.44	3.22	1.61	0.00	1.61	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	11.95	0.00	11.95	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	13.04	4.07	8.96	2.44	1.63	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	8.82	2.94	5.88	1.26	0.00	0.42	0.00	0.42
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	19.29	4.02	8.84	3.21	0.00	2.41	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	11.08	0.92	3.69	2.77	0.92	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	0.00	0.00	30.16	15.08	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	6.14	1.89	3.30	0.94	0.00	0.00	0.00	0.47
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	9.07	3.63	2.72	0.91	0.00	1.81	0.91	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	0.00	0.00	14.74	14.74	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	15.07	4.30	8.61	1.08	0.00	2.15	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	5.08	7.62	8.89	1.27	0.00	0.00	1.27	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	0.00	32.86	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	8.93	5.74	5.74	0.64	0.00	1.91	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	12.76	1.82	5.47	0.00	0.00	1.82	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	15.80	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	12.14	6.43	10.71	1.43	0.00	0.71	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	9.95	3.32	9.95	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	6.48	0.93	6.17	0.93	0.31	0.31	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	15.80	7.02	10.54	3.51	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	6.29	0.00	12.57	6.29	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	11.82	1.39	8.34	2.78	0.00	3.48	0.00	0.70
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	11.07	4.43	2.21	0.00	0.00	2.21	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	9.73	0.00	3.24	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	6.98	2.62	7.85	3.49	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	6.75	2.25	9.00	2.25	0.00	2.25	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	3.48	0.00	10.45	3.48	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	7.47	2.13	14.93	1.07	0.00	1.07	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	13.85	5.54	9.70	0.00	0.00	1.39	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	14.25	2.85	8.55	0.00	0.00	2.85	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	6.44	1.84	6.44	2.76	0.00	0.92	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	0.00	0.00	3.03	3.03	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	18.63	6.21	12.42	6.21	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	4.23	4.23	5.29	2.11	0.00	1.06	0.00	0.00
Keratinocyte - epidermal, donor1	11272-116H3	12.08	1.31	4.16	0.98	0.16	0.82	0.08	0.08
Keratinocyte - epidermal, donor2	11349-117G8	2.93	0.00	0.59	0.00	0.00	0.00	0.00	0.00
Keratinocyte - epidermal, donor3	11421-118F8	9.37	2.27	5.02	1.23	0.19	0.38	0.19	0.00
Keratinocyte - oral, donor1	11251-116E9	20.77	2.84	7.83	3.75	0.00	0.79	0.00	0.11
Keratocytes, donor1	11527-119I6	7.91	2.06	0.69	0.00	0.34	0.00	0.00	0.00
Keratocytes, donor2	11607-120I5	4.69	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Keratocytes, donor3	11688-122I5	11.86	0.59	0.00	0.00	0.00	0.00	0.00	0.00
Krukenberg tumor cell line:HSKTC	10687-109F3	54.95	4.40	6.59	0.00	0.00	2.20	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	9.71	3.24	1.08	2.16	0.00	0.00	0.00	0.00
Lens Epithelial Cells, donor2	11609-120I7	13.38	4.15	2.54	1.85	0.35	0.12	0.00	0.12
Lens Epithelial Cells, donor3	11690-122I7	11.60	6.05	2.93	2.52	0.10	0.10	0.40	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	10.32	5.69	1.66	0.83	0.47	0.00	0.36	0.12
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	8.09	4.19	1.40	0.56	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	9.44	4.88	1.10	0.79	0.63	0.00	0.16	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	8.60	4.30	2.15	1.08	0.54	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	6.62	4.10	0.32	0.32	0.00	0.00	0.00	0.32
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	4.74	3.13	0.54	0.32	0.11	0.11	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	9.44	1.64	0.00	0.41	1.23	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	3.29	2.28	0.76	0.51	0.51	0.25	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	4.79	3.66	0.84	0.14	0.14	0.28	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	9.89	3.96	0.40	0.79	0.40	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	5.23	2.91	0.97	0.78	0.39	0.19	0.19	0.19
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	4.07	1.67	0.56	0.56	0.19	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	5.92	3.83	2.09	0.70	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	5.49	3.34	0.72	0.48	0.24	0.00	0.00	0.24
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	4.53	4.67	0.55	0.82	0.14	0.14	0.00	0.14
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	6.78	3.39	0.92	1.85	0.31	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	4.36	2.81	0.94	0.31	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	5.31	2.74	1.46	1.10	0.55	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	5.59	5.59	2.63	1.32	0.33	0.33	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	3.81	1.46	0.59	0.29	0.59	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	4.23	2.24	0.25	0.00	0.50	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	6.30	7.27	2.42	1.94	0.97	0.00	0.48	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	7.27	2.96	0.27	0.54	0.27	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	5.75	4.09	1.82	0.91	0.15	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	10.37	5.70	1.56	0.00	0.52	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	8.17	4.82	2.51	0.63	0.63	0.00	0.21	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	5.26	3.91	1.80	0.45	0.45	0.30	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	7.57	1.38	1.38	0.00	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	5.46	3.39	1.51	0.19	0.19	0.56	0.19	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	4.24	3.50	0.95	0.64	0.00	0.32	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	4.36	2.42	2.42	0.00	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	5.29	2.65	0.99	1.32	0.00	0.00	0.33	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	4.21	3.47	0.74	0.50	0.25	0.12	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	6.29	7.40	2.22	0.74	0.74	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	3.95	1.73	0.99	0.25	0.25	0.00	0.00	0.49
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	4.12	2.47	1.79	0.69	0.41	0.00	0.00	0.14
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	8.04	5.79	2.25	0.96	0.32	0.00	0.32	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	5.78	4.26	1.52	1.83	0.00	0.30	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	6.86	5.60	2.24	0.84	0.56	0.14	0.00	0.14
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	5.33	5.69	0.36	0.36	0.36	0.00	0.36	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	6.79	2.42	0.48	0.48	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	5.29	2.49	0.93	0.62	0.00	0.00	0.00	0.16
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	6.45	3.58	1.07	0.72	0.00	0.36	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	4.25	1.96	1.63	0.33	0.00	0.00	0.33	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	2.83	0.94	1.88	0.24	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	8.91	4.58	1.36	0.62	0.25	0.12	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	5.12	3.07	0.26	0.77	0.26	0.00	0.51	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	4.18	2.09	1.19	0.60	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	15.86	2.27	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	14.58	0.77	9.21	4.60	0.00	0.00	0.77	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	10.39	2.23	4.45	5.20	0.00	0.74	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	17.77	2.12	5.50	1.69	0.00	0.85	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	16.18	2.11	5.63	1.41	0.00	0.00	0.00	0.70
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	9.34	0.93	2.80	0.93	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	12.88	1.55	5.67	2.06	0.00	0.00	0.52	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	7.14	0.00	5.95	3.57	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	9.73	3.17	4.98	2.26	0.00	0.23	0.00	0.23
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	10.18	2.91	6.40	1.74	0.00	0.87	0.00	0.29
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	9.90	3.60	2.25	4.05	0.45	2.25	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	14.36	3.39	5.15	2.30	0.14	0.95	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	11.81	1.54	4.62	4.62	0.00	0.51	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	13.06	0.71	4.94	3.53	0.00	0.35	0.00	0.35
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	9.33	2.67	4.00	0.67	0.00	0.00	0.00	1.33
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	16.30	1.53	3.57	2.04	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	13.87	1.07	5.87	1.33	0.00	0.80	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	11.71	2.08	4.16	1.51	0.57	1.13	0.00	0.19
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	7.36	3.07	4.29	0.61	0.00	2.45	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	21.20	0.82	6.52	4.89	0.00	2.45	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	13.74	2.50	6.04	2.08	0.21	0.83	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	12.05	2.24	3.64	1.68	0.28	1.12	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	11.33	0.00	4.12	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	13.35	2.03	5.81	3.48	0.58	1.45	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	12.26	2.69	3.29	1.79	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	12.17	1.11	6.09	4.43	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	16.26	1.41	3.89	1.77	0.00	1.41	0.35	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	13.64	2.95	7.38	1.48	0.00	2.58	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	18.42	0.00	5.76	3.45	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	13.05	3.07	5.37	2.69	0.38	0.38	0.00	0.38
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	12.45	2.26	2.26	4.53	0.57	0.57	0.00	0.57
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	11.49	1.64	4.10	4.10	0.00	0.00	0.00	0.82
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	11.75	1.36	8.13	4.97	0.45	0.00	0.00	0.45
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	10.05	3.59	6.46	1.44	0.00	2.15	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	8.22	2.24	5.23	2.99	0.00	0.75	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	16.72	3.72	3.72	2.23	0.74	1.11	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	11.20	3.45	5.60	1.72	0.00	1.72	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	11.99	0.86	5.14	3.43	0.00	0.86	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	12.66	2.67	6.00	3.00	0.00	0.67	0.00	0.33
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	13.88	3.62	3.62	3.62	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	14.22	1.42	6.40	2.84	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	14.78	3.44	5.50	1.37	0.00	0.34	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	17.18	3.76	5.90	3.22	0.54	0.54	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	14.14	3.37	6.06	2.69	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	15.93	2.59	5.56	5.19	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	4.65	3.49	8.14	0.00	0.00	1.16	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	11.64	0.00	6.35	2.12	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	9.60	2.00	4.80	1.20	0.00	1.20	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	16.72	4.36	7.27	3.63	0.00	2.18	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	16.10	3.83	6.90	1.53	0.00	0.77	0.00	0.77
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	12.83	5.43	5.92	2.47	0.00	2.47	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	24.46	0.94	6.59	1.88	0.00	0.94	0.00	0.94
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	14.08	3.02	4.53	3.02	0.50	1.01	0.00	0.50
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	22.53	0.90	7.21	2.70	0.00	2.25	0.45	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	18.93	0.00	8.61	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	16.03	1.34	4.01	2.67	0.00	0.89	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	16.81	4.30	7.43	3.91	0.00	1.17	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	13.19	4.62	5.28	1.98	0.00	1.32	0.66	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	13.49	4.15	2.59	4.67	0.52	1.04	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	20.13	2.63	8.31	3.94	0.00	0.88	0.00	0.44
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	12.86	2.24	7.27	5.03	0.00	0.56	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	11.92	2.21	3.97	3.53	0.00	2.21	0.44	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	15.43	2.31	2.70	4.24	0.00	0.77	0.39	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	11.14	3.04	5.06	2.53	0.00	0.51	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	14.42	1.44	7.21	1.44	0.00	1.92	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	13.12	4.37	5.96	3.18	0.00	0.80	0.00	1.19
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	15.19	3.04	7.29	2.43	0.00	1.82	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	19.37	3.46	4.84	1.38	0.00	1.38	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	14.82	4.94	1.14	1.90	0.38	0.76	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	13.43	3.10	6.20	3.10	0.00	0.52	0.52	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	14.51	0.60	3.02	2.42	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	14.26	1.90	3.80	2.85	0.00	1.58	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	12.79	2.13	4.26	3.73	0.00	0.53	0.00	0.53
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	13.22	1.72	6.32	2.87	0.00	0.57	0.00	0.57
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	13.88	4.11	4.63	2.57	0.00	1.03	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	14.15	2.12	7.78	2.83	0.00	0.71	0.71	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	14.75	2.27	2.27	1.13	0.00	0.57	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	10.82	2.08	4.99	4.16	0.42	1.25	0.42	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	12.53	1.57	4.70	6.26	0.00	0.78	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	10.86	1.25	6.68	0.84	0.42	2.09	0.42	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	14.40	3.72	5.11	3.72	0.00	1.39	0.00	0.46
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	12.71	2.68	4.01	3.35	0.00	0.00	0.00	0.67
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	11.76	4.28	3.74	3.21	1.60	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	16.16	3.64	4.45	4.45	0.81	1.21	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	13.77	3.67	5.51	5.51	0.00	0.92	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	15.11	0.89	10.67	7.11	0.00	2.67	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	11.97	3.42	4.56	5.13	0.00	2.28	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	12.27	3.83	3.83	3.07	0.77	1.53	0.77	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	16.42	2.19	5.47	2.74	0.00	1.09	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	11.58	4.45	6.68	2.23	0.00	2.23	0.00	0.89
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	11.18	3.12	5.72	1.82	0.26	1.04	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	15.91	2.65	3.32	1.99	0.00	0.66	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	12.47	4.16	6.24	2.08	0.00	6.24	0.00	0.00
Macrophage - monocyte derived, donor1	11232-116C8	13.67	3.87	0.23	0.23	0.23	0.23	0.00	0.00
Macrophage - monocyte derived, donor2	11313-117C8	6.61	5.51	0.00	0.92	1.10	0.18	0.00	0.00
Macrophage - monocyte derived, donor3	11389-118C3	11.93	6.16	0.39	0.26	0.52	0.52	0.13	0.00
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	2.66	3.19	2.66	0.53	0.00	0.00	0.00	0.00
Mallassez-derived cells, donor2	11929-125I3	16.80	4.28	5.07	1.58	0.16	0.63	0.16	0.00
Mallassez-derived cells, donor3	11930-125I4	10.42	3.47	4.17	2.78	0.00	0.42	0.00	0.00
Mammary Epithelial Cell, donor1	11273-116H4	16.14	2.99	9.37	3.09	0.30	1.10	0.00	0.40
Mammary Epithelial Cell, donor2	11350-117G9	13.03	4.05	8.11	2.61	0.00	0.87	0.29	0.58
Mammary Epithelial Cell, donor3	11422-118F9	7.98	4.49	3.99	1.00	0.25	0.25	0.00	0.00
Mast cell - stimulated, donor1	11487-119E2	27.12	35.25	0.68	6.10	47.46	0.68	1.36	0.00
Mast cell, donor1	11563-120D6	20.65	23.57	1.62	1.84	11.14	0.11	0.22	0.11
Mast cell, donor2	11565-120D8	28.23	11.00	2.08	1.19	1.49	0.59	0.59	0.00
Mast cell, donor3	11566-120D9	31.07	6.75	0.68	1.58	0.45	0.00	0.45	0.00
Mast cell, donor4	11567-120E1	28.54	9.22	0.35	1.95	0.71	0.00	0.53	0.00
Mast cell, expanded and stimulated, donor5	11940-126A5	17.30	24.40	3.88	3.11	5.54	0.11	0.00	0.00
Mast cell, expanded and stimulated, donor8	11942-126A7	6.42	16.34	2.33	1.75	14.01	0.00	0.00	0.00
Mast cell, expanded, donor5	11939-126A4	25.12	15.14	0.92	0.57	1.26	0.00	0.34	0.00
Mast cell, expanded, donor8	11941-126A6	30.13	28.12	1.67	1.84	7.53	0.00	0.17	0.33
Melanocyte - dark, donor1	11502-119F8	7.26	7.56	2.39	0.90	0.60	0.00	0.30	0.10
Melanocyte - dark, donor2	11582-120F7	10.73	3.11	1.73	1.04	0.00	0.00	0.35	0.00
Melanocyte - dark, donor3	11663-122F7	15.50	5.58	0.65	1.16	0.51	0.22	0.07	0.07
Melanocyte - light, donor1	11274-116H5	8.70	1.88	0.94	0.47	0.00	0.00	0.00	0.00
Melanocyte - light, donor2	11351-117H1	9.55	4.09	0.00	0.00	0.00	0.00	0.00	0.00
Melanocyte - light, donor3	11423-118G1	6.07	2.60	0.87	0.00	0.00	0.00	0.00	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	11.77	4.58	0.42	1.04	0.31	0.00	0.00	0.00
Melanocyte, donor2 (MC+2)	12739-135I3	7.53	4.57	1.08	0.00	0.00	0.27	0.00	0.00
Melanocyte, donor3 (MC+3)	12837-137B2	16.07	3.75	0.27	0.80	0.27	0.00	0.00	0.00
Meningeal Cells, donor1	11493-119E8	14.76	7.32	1.49	0.74	0.37	0.00	0.37	0.25
Meningeal Cells, donor2	11573-120E7	9.68	4.84	0.88	1.32	0.00	0.44	0.00	0.00
Meningeal Cells, donor3	11654-122E7	13.53	8.80	3.18	1.14	0.49	0.33	0.00	0.24
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	10.27	5.13	1.14	0.57	0.57	0.00	0.00	0.00
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	7.95	4.43	2.42	1.61	0.00	0.60	0.20	0.10
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	3.94	1.31	0.00	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	9.16	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	7.89	5.02	0.00	0.00	0.72	0.00	0.00	0.00
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	11.65	3.81	3.39	1.48	0.00	0.21	0.21	0.00
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	12.57	3.52	3.02	1.51	0.00	0.50	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	7.03	4.40	0.88	0.44	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	9.50	2.19	0.73	0.00	0.00	0.73	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	6.34	3.48	0.20	0.61	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	10.11	2.77	1.11	0.28	0.42	0.00	0.00	0.00
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	2.97	2.97	1.12	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	14.60	3.42	2.11	1.18	0.13	0.13	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	5.64	0.89	0.00	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	2.34	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	5.76	2.56	1.28	1.28	0.00	0.00	0.00	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	9.57	7.44	1.42	0.35	0.00	0.00	0.00	0.00
Mesenchymal stem cells - hepatic, donor0	11218-116B3	14.07	3.75	1.56	0.00	0.31	0.63	0.00	0.00
Mesenchymal stem cells - umbilical, donor0	11214-116A8	7.26	1.45	2.90	1.45	0.00	0.00	0.00	0.00
Mesothelial Cells, donor1	11247-116E5	11.40	4.77	1.33	1.33	0.00	0.00	0.00	0.27
Mesothelial Cells, donor2	12156-128G5	5.51	1.50	2.00	1.00	0.00	0.00	0.00	0.50
Mesothelial Cells, donor3	11402-118D7	6.50	3.97	2.24	1.01	0.14	0.22	0.14	0.14
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	9.45	6.75	0.00	2.70	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	9.85	6.16	0.74	0.74	0.74	0.00	0.25	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	7.66	7.95	0.59	1.18	0.59	0.29	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	3.46	6.91	0.00	0.00	6.91	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	7.13	4.03	0.31	0.31	0.62	0.31	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	4.36	4.56	0.83	1.24	0.21	0.21	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	9.26	6.95	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	9.01	4.75	0.25	0.00	0.50	0.00	0.25	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	9.31	3.72	0.47	0.93	1.86	0.47	0.47	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	11.58	3.25	0.41	0.81	0.61	0.41	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	5.94	3.56	0.40	1.58	1.58	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	8.55	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	4.42	3.54	0.00	0.88	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	4.94	4.18	0.38	1.14	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	5.26	5.26	0.00	0.00	1.32	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	7.64	2.55	0.00	0.00	0.21	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	2.76	2.76	0.00	0.00	0.92	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	7.75	5.37	0.00	0.30	0.30	0.00	0.30	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	16.77	1.68	0.00	0.00	1.68	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	8.03	3.26	0.25	0.50	0.00	0.75	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	5.70	4.28	0.00	1.90	0.24	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	3.32	7.19	0.00	1.11	1.11	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	7.14	4.60	0.69	1.61	0.23	0.46	0.23	0.23
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	6.10	5.68	0.21	1.26	0.00	0.63	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	5.71	7.95	0.20	1.83	1.83	0.82	0.41	0.20
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	7.29	3.43	0.21	0.64	0.43	0.43	0.86	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	8.00	4.89	0.00	0.89	0.89	0.22	0.22	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	8.10	6.57	0.66	1.10	1.10	0.66	0.66	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	4.06	6.59	0.00	1.52	2.03	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	6.63	9.94	0.00	0.00	3.31	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	7.88	7.61	0.27	0.54	1.63	0.54	1.09	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	7.94	7.94	0.29	1.18	1.47	0.00	0.88	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	3.27	9.81	0.00	1.09	3.27	0.00	2.18	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	2.88	5.77	0.48	0.96	1.44	0.48	0.96	0.48
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	4.80	9.61	0.80	0.80	1.20	0.40	1.60	0.40
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	8.23	5.48	0.00	2.74	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	9.51	7.51	0.00	3.00	3.50	0.50	0.50	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	8.15	0.00	0.00	6.12	2.04	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	10.07	10.07	0.00	2.19	3.50	0.00	1.31	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	3.31	4.41	0.00	2.21	0.00	1.10	1.10	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	7.68	6.40	0.00	1.28	0.64	0.00	0.64	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	7.69	10.91	0.50	1.74	1.74	0.74	0.50	0.25
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	4.87	9.05	0.00	0.00	2.09	0.00	0.70	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	6.63	4.42	0.00	2.21	2.21	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	5.81	4.79	0.00	0.68	0.00	0.68	1.37	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	6.56	7.00	0.00	1.31	0.44	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	12.43	6.04	0.36	1.07	0.36	0.00	0.36	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	5.33	7.01	1.40	0.84	0.28	1.12	1.12	0.28
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	5.40	12.88	0.00	0.83	1.66	0.42	0.83	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	11.65	7.58	0.00	0.00	1.17	1.17	0.58	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	10.56	9.65	0.60	1.21	0.90	0.60	0.30	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	4.59	8.77	0.42	1.25	0.83	0.83	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	28.88	7.22	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	10.16	4.62	0.92	0.92	0.00	0.92	1.85	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	8.54	5.12	1.14	2.28	0.57	0.57	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	13.13	5.67	0.41	0.97	0.55	0.14	0.55	0.14
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	7.77	5.18	0.26	1.55	0.52	0.26	0.26	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	6.01	6.43	1.29	2.57	0.00	0.86	0.86	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	10.16	5.08	0.00	0.64	1.27	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	10.14	6.14	0.80	0.53	1.60	0.00	0.27	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	8.38	5.99	0.90	0.60	0.90	0.60	0.00	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	8.76	4.24	0.28	0.85	0.28	0.14	0.28	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	8.92	5.41	0.64	0.64	0.32	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	7.74	9.29	0.22	1.33	0.44	0.00	0.22	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	9.48	4.17	0.00	0.38	0.00	0.38	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	6.82	5.11	1.14	0.57	0.57	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	6.88	7.13	0.25	0.98	0.98	0.25	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	12.38	1.30	0.00	1.30	0.00	0.65	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	8.53	5.00	0.59	0.88	0.00	0.00	0.29	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	8.94	4.61	0.29	1.15	0.58	0.29	0.58	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	12.78	4.95	0.41	0.41	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	12.51	5.36	0.60	0.89	0.00	0.30	0.60	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	3.56	5.35	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	7.89	2.96	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	6.31	7.36	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	7.71	3.16	0.20	0.40	0.40	0.20	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	13.97	4.66	0.00	0.93	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	7.51	2.25	0.00	0.38	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	4.53	2.13	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	7.46	1.92	0.00	0.45	0.34	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	4.42	1.47	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	8.06	1.47	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	6.22	1.56	0.00	1.56	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	5.88	1.07	0.00	0.53	0.00	0.00	0.53	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	0.00	7.73	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	4.04	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	7.17	2.11	0.00	0.00	0.00	0.42	0.42	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	10.90	0.00	0.00	1.36	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	0.64	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	0.81	0.00	0.00	0.00	0.00	0.00	0.81	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	4.53	3.02	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	22.84	5.71	5.71	0.00	0.00	0.00	5.71	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	9.79	9.79	9.79	0.00	3.26	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	0.00	4.75	0.00	4.75	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	0.00	0.00	0.00	12.55	0.00	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	13.57	6.68	1.72	2.37	0.22	0.22	0.22	0.22
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	16.72	1.57	1.57	0.52	0.52	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	11.35	6.67	0.00	0.00	0.00	0.67	0.67	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	9.18	1.25	0.83	0.42	0.00	0.00	0.42	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	38.03	4.94	0.76	1.14	0.57	0.19	0.19	0.00
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	20.75	7.98	0.00	1.60	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	6.80	4.76	0.68	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	18.38	3.68	0.00	1.84	3.68	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	10.88	4.60	0.00	0.84	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	8.37	3.02	0.00	0.23	0.00	0.23	0.23	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	14.32	6.22	0.00	1.35	0.00	0.54	0.27	0.00
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	12.61	5.26	1.26	0.42	0.00	0.21	0.00	0.21
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	0.00	11.13	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	12.41	4.96	0.00	0.50	0.50	0.00	0.99	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	14.35	2.44	0.54	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	6.80	3.63	0.23	0.91	0.23	0.23	0.23	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	14.70	4.08	0.16	0.16	0.16	0.16	0.16	0.00
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	13.67	6.01	0.55	1.28	0.18	0.00	0.00	0.00
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	10.08	6.37	1.06	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	7.80	4.20	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	28.55	4.92	0.66	0.33	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	10.41	3.09	0.00	0.49	0.33	0.00	0.16	0.00
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	13.93	6.88	0.18	0.35	0.35	0.00	0.00	0.00
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	11.95	2.81	0.00	0.70	0.00	0.70	0.00	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	8.73	2.30	0.00	0.46	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	12.21	3.21	0.00	0.64	0.00	0.96	0.32	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	24.83	3.10	0.69	0.69	0.34	0.00	0.00	0.34
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	30.34	10.11	5.06	0.00	5.06	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	12.92	5.57	0.45	0.67	0.45	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	8.89	2.96	0.00	0.85	0.00	0.42	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	12.10	2.14	0.24	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	8.58	4.29	0.43	0.43	0.86	0.00	0.43	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	18.06	9.03	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	17.99	2.67	0.00	1.33	0.33	0.00	0.33	0.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	15.78	4.06	0.00	1.80	0.45	0.00	0.45	0.45
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	8.33	3.57	0.40	0.79	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	9.29	1.86	0.93	0.93	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	17.41	3.03	0.38	1.14	0.00	1.14	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	12.06	4.56	0.98	1.63	0.33	0.98	1.30	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	17.87	2.18	0.00	0.87	0.44	0.00	0.44	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	18.54	5.43	0.00	0.90	0.45	0.45	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	8.82	4.41	0.00	1.76	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	9.31	4.65	1.33	0.00	0.66	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	10.91	2.48	0.50	1.98	0.50	0.99	0.99	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	12.25	1.53	0.77	0.77	0.00	0.38	0.38	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	13.31	6.35	0.91	0.91	0.00	0.00	0.30	0.00
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	16.58	6.63	0.66	1.77	0.22	0.88	0.00	0.44
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	9.49	3.39	0.00	2.03	0.00	0.68	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	30.66	5.11	5.11	5.11	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	4.88	1.83	0.00	2.44	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	16.68	1.89	0.31	1.26	0.31	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	13.01	2.42	0.61	1.82	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	15.03	3.96	0.00	0.00	1.58	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	32.88	4.53	2.27	1.13	0.00	1.13	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	15.17	5.06	0.00	5.06	0.00	0.00	0.00	0.00
Myoblast, donor1	11241-116D8	8.20	4.10	0.50	1.12	0.00	0.00	0.00	0.00
Myoblast, donor2	11322-117D8	9.01	4.41	0.38	0.77	0.38	0.38	0.00	0.00
Myoblast, donor3	11398-118D3	11.10	6.39	1.68	0.50	0.50	0.34	0.50	0.00
NK T cell leukemia cell line:KHYG-1	10777-110G3	18.68	12.55	8.17	2.33	0.58	0.88	0.29	0.29
Natural Killer Cells, donor1	11230-116C6	21.22	33.83	7.07	3.38	12.92	0.62	1.54	1.54
Natural Killer Cells, donor2	11311-117C6	15.68	28.65	4.82	5.73	14.17	0.60	2.11	1.21
Natural Killer Cells, donor3	11387-118C1	14.17	21.90	5.71	3.68	8.65	0.74	0.92	1.29
Neural stem cells, donor1	11275-116H6	38.83	11.61	3.63	5.81	1.09	0.73	0.00	0.36
Neural stem cells, donor2	11352-117H2	44.29	5.78	3.85	7.70	0.00	1.93	0.00	0.00
Neurons, donor1	11494-119E9	10.24	5.69	1.14	3.41	0.00	0.00	0.00	0.00
Neurons, donor2	11574-120E8	17.39	3.52	3.74	1.76	0.00	0.44	0.00	0.00
Neurons, donor3	11655-122E8	22.20	1.64	2.47	3.29	0.82	1.64	0.00	0.00
Neutrophils, donor1	11233-116C9	37.12	16.70	1.86	4.64	7.42	0.93	1.86	0.00
Neutrophils, donor2	11314-117C9	23.19	20.29	0.00	0.00	8.70	0.00	0.00	0.00
Neutrophils, donor3	11390-118C4	73.91	45.20	2.44	4.28	7.33	0.00	1.83	0.61
Nucleus Pulposus Cell, donor1	11252-116F1	14.84	5.58	1.07	0.71	0.00	0.00	0.24	0.00
Nucleus Pulposus Cell, donor2	11409-118E5	3.26	1.95	0.98	0.98	0.00	0.33	0.00	0.00
Nucleus Pulposus Cell, donor3	11462-119B4	6.42	2.01	0.20	0.00	0.00	0.00	0.00	0.00
Olfactory epithelial cells, donor1	11933-125I7	11.98	2.20	0.83	0.28	0.28	0.00	0.14	0.14
Olfactory epithelial cells, donor2	11934-125I8	9.84	1.45	0.72	1.01	0.00	0.29	0.00	0.00
Olfactory epithelial cells, donor3	11935-125I9	9.65	1.36	0.79	0.45	0.11	0.11	0.00	0.00
Olfactory epithelial cells, donor4	11936-126A1	15.88	3.60	0.68	0.29	0.29	0.10	0.10	0.00
Oligodendrocyte - precursors, donor1	11496-119F2	15.05	2.41	6.02	0.60	0.60	0.60	0.00	0.00
Osteoblast - differentiated, donor1	11276-116H7	8.30	2.13	0.21	0.85	0.64	0.00	0.00	0.00
Osteoblast - differentiated, donor2	11353-117H3	1.14	0.00	1.14	1.14	0.00	0.00	1.14	0.00
Osteoblast - differentiated, donor3	11425-118G3	4.34	3.72	0.62	0.00	0.00	0.00	0.00	0.00
Osteoblast, donor1	11277-116H8	6.06	3.91	2.35	0.00	0.39	0.20	0.00	0.20
Osteoblast, donor2	11354-117H4	16.86	8.43	3.51	1.40	0.70	0.00	0.70	0.00
Osteoblast, donor3	11426-118G4	9.42	5.87	1.60	1.24	1.60	0.00	0.00	0.18
Pancreatic stromal cells, donor1	11249-116E7	14.40	3.87	1.43	0.51	0.00	0.08	0.00	0.08
Pericytes, donor1	11491-119E6	4.34	1.34	0.33	0.11	0.22	0.00	0.22	0.11
Pericytes, donor2	11571-120E5	4.98	1.13	0.68	0.23	0.23	0.00	0.23	0.00
Pericytes, donor3	11652-122E5	3.87	3.05	0.61	0.41	0.00	0.20	0.20	0.20
Perineurial Cells, donor1	11499-119F5	12.88	3.16	1.47	1.36	0.00	0.00	0.00	0.00
Perineurial Cells, donor2	11579-120F4	9.20	7.27	2.48	0.46	0.46	0.09	0.18	0.00
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	35.38	24.54	10.52	2.87	5.10	0.00	0.00	0.96
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	18.12	11.02	4.65	2.45	2.69	0.24	0.73	0.73
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	18.12	17.73	5.05	1.94	9.58	0.65	1.16	0.52
Placental Epithelial Cells, donor1	11278-116H9	4.78	1.43	1.43	0.24	0.00	0.00	0.00	0.00
Placental Epithelial Cells, donor2	11355-117H5	7.76	0.00	2.22	0.00	0.00	0.00	0.00	0.00
Placental Epithelial Cells, donor3	11427-118G5	2.94	2.94	2.75	0.59	0.00	0.20	0.00	0.00
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	8.54	0.95	1.27	0.32	0.63	0.00	0.00	0.00
Preadipocyte - breast, donor1	11467-119B9	11.82	5.44	2.44	1.13	0.19	0.00	0.19	0.00
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	22.58	10.18	3.13	1.70	0.00	0.39	0.26	0.13
Preadipocyte - breast, donor2	11328-117E5	11.48	4.50	1.58	1.13	0.00	0.90	0.23	0.23
Preadipocyte - omental, donor1	11468-119C1	14.71	4.16	1.92	0.75	0.32	0.32	0.00	0.00
Preadipocyte - omental, donor2	11329-117E6	17.46	5.24	2.18	2.18	0.44	0.00	0.00	0.00
Preadipocyte - omental, donor3	11403-118D8	9.31	4.87	2.29	1.43	0.29	0.29	0.00	0.14
Preadipocyte - perirenal, donor1	11469-119C2	2.95	1.97	0.00	0.00	0.00	0.00	0.00	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	4.61	3.69	0.31	3.38	0.00	0.31	0.61	0.00
Preadipocyte - subcutaneous, donor2	11356-117H6	10.09	9.92	2.83	1.59	0.53	0.00	0.53	0.18
Preadipocyte - subcutaneous, donor3	11428-118G6	6.13	4.94	1.70	0.34	0.34	0.34	0.00	0.00
Preadipocyte - visceral, donor1	11280-116I2	13.51	11.08	1.77	1.40	0.09	0.28	0.47	0.00
Preadipocyte - visceral, donor2	11357-117H7	9.66	7.36	1.84	1.84	0.00	0.00	0.00	0.00
Preadipocyte - visceral, donor3	11429-118G7	8.88	7.73	0.94	1.15	0.10	0.10	0.31	0.00
Prostate Epithelial Cells (polarized), donor1	11253-116F2	14.33	7.09	6.79	3.47	0.00	0.91	0.30	0.15
Prostate Epithelial Cells, donor2	11331-117E8	8.40	2.44	4.33	1.08	0.14	0.14	0.00	0.14
Prostate Epithelial Cells, donor3	11404-118D9	10.72	0.12	1.84	0.98	0.12	0.06	0.06	0.00
Prostate Stromal Cells, donor1	11254-116F3	8.54	4.78	1.48	0.80	0.00	0.34	0.00	0.00
Prostate Stromal Cells, donor2	11332-117E9	8.96	3.94	1.97	0.72	0.00	0.18	0.00	0.00
Prostate Stromal Cells, donor3	11405-118E1	6.36	2.50	0.94	0.52	0.21	0.00	0.42	0.10
Renal Cortical Epithelial Cells, donor1	11516-119H4	6.20	2.55	1.46	0.73	0.00	0.00	0.36	0.00
Renal Cortical Epithelial Cells, donor2	11596-120H3	16.70	2.91	3.40	1.59	0.07	0.62	0.14	0.00
Renal Epithelial Cells, donor1	11517-119H5	6.59	1.52	1.52	1.01	0.00	0.00	0.00	0.00
Renal Epithelial Cells, donor2	11597-120H4	7.82	1.42	2.13	0.00	0.00	0.00	0.00	0.71
Renal Epithelial Cells, donor3	11678-122H4	19.69	3.71	2.86	2.01	0.42	0.32	0.00	0.11
Renal Glomerular Endothelial Cells, donor1	11514-119H2	2.72	4.09	0.00	2.04	0.68	0.00	0.00	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	7.95	4.85	0.67	0.54	0.27	0.27	0.00	0.00
Renal Glomerular Endothelial Cells, donor3	11675-122H1	12.21	7.77	3.33	2.00	0.67	0.67	0.22	0.22
Renal Glomerular Endothelial Cells, donor4	11783-124B1	2.66	3.33	0.67	0.00	0.00	0.00	0.00	0.00
Renal Mesangial Cells, donor1	11518-119H6	5.72	2.20	0.66	0.22	0.22	0.22	0.22	0.00
Renal Mesangial Cells, donor2	11598-120H5	6.90	4.39	3.76	0.00	0.00	0.00	0.00	0.00
Renal Mesangial Cells, donor3	11679-122H5	3.05	2.50	1.94	0.83	0.00	0.28	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	18.79	4.56	4.56	0.81	0.00	0.54	0.00	0.27
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	10.96	0.42	2.53	0.42	0.00	0.84	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	10.22	2.51	3.09	0.77	0.00	0.00	0.00	0.00
Retinal Pigment Epithelial Cells, donor0	11215-116A9	17.11	2.59	2.59	1.81	0.52	0.00	0.00	0.00
Retinal Pigment Epithelial Cells, donor1	11528-119I7	11.09	1.71	1.71	0.57	0.00	0.00	0.00	0.00
Retinal Pigment Epithelial Cells, donor2	11608-120I6	7.20	2.06	1.03	0.00	0.00	0.00	0.00	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	14.30	0.50	2.51	0.75	0.00	0.00	0.00	0.00
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	25.12	5.75	6.01	1.87	0.00	0.27	0.00	0.13
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	53.60	12.51	3.57	3.57	0.89	0.00	0.00	0.89
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	67.15	6.60	6.60	10.46	0.55	1.65	0.00	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	83.53	8.12	7.54	10.44	0.58	2.32	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	53.31	14.43	6.76	2.60	0.65	0.13	0.39	0.52
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	51.64	16.09	7.45	2.38	0.50	0.60	0.20	0.10
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	45.51	19.85	6.92	3.68	1.12	0.78	0.11	0.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	52.84	17.37	8.19	2.73	0.37	0.74	0.12	0.50
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	47.43	13.17	7.34	3.26	0.82	0.58	0.00	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	57.55	20.80	9.01	2.54	0.69	0.92	0.69	0.46
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	54.35	13.14	9.58	1.51	0.82	0.27	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	50.83	15.28	5.45	2.72	1.36	0.61	0.45	0.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	43.90	16.31	6.27	2.15	0.90	0.90	0.36	0.36
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	51.21	12.05	6.89	2.73	0.72	1.15	0.57	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	41.32	13.63	7.40	3.33	0.54	0.54	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	38.28	12.61	7.30	2.21	0.89	0.22	0.44	0.44
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	63.47	10.32	6.69	2.10	0.96	0.38	0.19	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	49.94	14.25	7.83	1.96	0.84	0.65	0.19	0.09
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	66.33	21.42	11.84	5.45	1.13	1.13	0.00	0.38
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	56.67	12.74	5.18	2.52	0.40	0.93	0.53	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	46.72	15.38	8.76	1.65	0.58	0.49	0.10	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	46.78	16.80	8.98	4.01	1.15	1.34	0.57	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	54.25	13.24	5.98	2.56	0.53	0.43	0.53	0.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	47.93	16.26	5.05	1.68	0.84	1.12	0.56	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	50.24	17.77	7.69	2.56	0.68	0.34	0.85	0.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	56.70	11.67	7.11	1.82	0.73	0.91	0.18	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	42.92	13.49	7.73	2.58	0.61	0.86	0.49	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	44.33	13.70	5.51	2.15	0.40	1.07	0.67	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	55.90	13.21	7.31	2.83	1.42	0.71	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	44.25	15.08	5.95	2.98	0.60	0.60	0.40	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	57.06	17.07	6.31	2.57	1.64	0.47	0.23	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	55.16	10.99	5.81	3.53	0.62	0.62	0.00	0.41
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	57.96	15.93	6.42	3.76	0.66	0.00	0.22	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	48.46	16.29	8.15	3.13	0.84	1.25	0.00	0.63
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	53.83	14.54	7.81	3.36	0.27	1.21	0.81	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	44.45	11.41	5.11	3.07	1.36	0.85	0.17	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	47.23	16.39	7.13	2.12	0.77	2.51	0.19	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	69.81	14.44	6.88	4.13	1.03	0.86	0.17	0.69
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	49.79	14.68	7.68	2.61	0.69	0.55	0.27	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	53.36	16.58	9.36	3.12	0.33	0.66	0.66	0.33
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	69.54	9.88	7.50	3.41	0.51	0.34	0.17	0.51
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	45.13	16.57	7.25	2.52	0.44	0.44	0.15	0.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	44.78	17.33	9.60	3.20	0.53	0.53	0.53	0.53
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	57.52	8.30	4.84	2.21	0.14	0.83	0.14	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	45.48	13.10	7.14	3.10	0.71	0.48	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	68.32	19.95	8.26	3.63	0.60	1.01	0.20	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	50.85	9.89	6.22	2.07	0.47	0.38	0.09	0.09
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	47.86	13.97	11.88	3.84	0.35	0.35	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	40.50	11.79	6.04	2.42	0.30	1.21	0.30	0.91
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	46.51	11.99	6.49	3.06	0.49	0.86	0.37	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	93.01	27.80	19.50	9.17	3.06	2.18	0.73	0.73
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	38.94	12.78	4.87	1.22	2.43	1.22	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	42.50	11.75	6.33	4.22	0.60	0.90	0.30	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	48.18	10.63	7.69	4.30	1.81	0.68	0.00	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	53.32	17.67	6.29	4.49	1.80	0.30	0.30	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	46.52	10.27	6.85	4.37	0.12	0.35	0.24	0.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	51.65	16.22	8.11	5.12	1.28	0.85	0.64	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	58.90	16.23	9.01	4.81	1.20	0.60	1.20	0.00
Schwann Cells, donor1	11498-119F4	6.58	2.63	0.56	0.19	0.19	0.19	0.00	0.00
Schwann Cells, donor2	11578-120F3	6.80	3.40	0.00	0.00	0.00	0.00	0.00	0.00
Schwann Cells, donor3	11659-122F3	10.08	6.79	2.63	1.10	0.00	0.00	0.00	0.00
Sebocyte, donor1	11220-116B5	13.15	5.48	6.03	1.10	0.00	0.55	0.00	0.00
Sebocyte, donor2	11301-117B5	8.27	1.38	1.38	0.92	0.00	0.00	0.00	0.00
Sebocyte, donor3	11378-118B1	6.80	1.44	1.24	0.62	0.21	0.21	0.00	0.00
Sertoli Cells, donor1	11255-116F4	8.28	3.31	0.00	3.31	1.66	0.00	0.00	1.66
Sertoli Cells, donor2	11333-117F1	8.47	0.00	0.00	2.82	0.00	0.00	2.82	0.00
Skeletal Muscle Cells, donor1	11281-116I3	10.03	3.96	1.50	0.70	0.00	0.09	0.00	0.09
Skeletal Muscle Cells, donor2	11358-117H8	3.61	0.00	0.72	0.00	0.00	0.00	0.00	0.00
Skeletal Muscle Cells, donor3	11430-118G8	9.20	6.69	1.67	0.84	0.84	0.84	0.00	0.00
Skeletal Muscle Cells, donor4	11451-119A2	9.58	5.18	0.79	0.31	0.63	0.47	0.16	0.00
Skeletal Muscle Cells, donor5	11455-119A6	12.78	7.88	1.19	0.89	0.15	0.15	0.00	0.00
Skeletal Muscle Cells, donor6	11459-119B1	14.16	7.08	1.54	1.08	0.31	0.00	0.00	0.00
Skeletal Muscle Satellite Cells, donor1	11240-116D7	19.15	8.32	1.89	1.64	0.13	0.13	0.13	0.00
Skeletal Muscle Satellite Cells, donor2	11321-117D7	11.99	7.28	2.14	0.57	0.29	0.29	0.14	0.14
Skeletal Muscle Satellite Cells, donor3	11397-118D2	13.00	9.52	2.18	1.49	1.29	0.20	0.30	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	12.47	6.07	1.10	1.85	0.76	0.34	0.34	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	3.62	3.62	0.72	0.00	0.00	0.00	0.00	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	3.30	4.54	0.55	0.69	0.41	0.00	0.00	0.00
Skin - palm, donor1	10286-104F7	24.17	2.69	5.37	0.00	0.00	0.00	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	8.51	2.02	1.87	1.15	0.00	0.58	0.14	0.14
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	48.26	9.00	17.18	11.45	0.82	2.45	0.00	0.82
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	8.18	2.08	3.76	2.08	0.00	0.52	0.00	0.13
Small Airway Epithelial Cells, donor1	11256-116F5	15.15	0.70	5.56	2.50	0.00	0.97	0.00	0.00
Small Airway Epithelial Cells, donor2	11334-117F2	7.60	1.69	6.05	1.13	0.14	1.41	0.00	0.14
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	30.87	11.63	16.07	6.55	0.63	3.17	0.63	0.63
Small Airway Epithelial Cells, donor3	11406-118E2	10.42	0.67	4.65	1.95	0.22	0.82	0.22	0.00
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	8.64	0.62	0.93	0.31	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	17.79	4.89	2.00	1.56	0.44	0.00	0.00	0.00
Smooth Muscle Cells - Aortic, donor0	11210-116A4	8.23	2.35	1.76	0.59	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Aortic, donor1	11283-116I5	6.19	2.21	0.88	1.10	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Aortic, donor2	11360-117I1	8.27	3.94	0.79	0.39	0.00	0.79	0.00	0.00
Smooth Muscle Cells - Aortic, donor3	11432-118H1	7.73	6.95	0.00	0.77	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	15.01	4.00	0.00	1.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	6.52	3.06	1.06	0.27	0.00	0.27	0.00	0.13
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	8.20	3.55	0.44	0.89	0.44	0.22	0.22	0.00
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	8.07	4.23	1.41	0.64	0.26	0.13	0.00	0.00
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	7.81	8.47	1.95	0.33	0.33	0.00	0.00	0.00
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	12.99	7.68	1.77	1.77	0.30	0.30	0.00	0.00
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	9.97	4.70	1.28	0.71	0.71	0.43	0.28	0.00
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	2.93	0.65	0.16	0.16	0.00	0.16	0.00	0.00
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	8.22	2.13	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor1	11285-116I7	9.09	5.81	1.01	0.51	0.25	0.51	0.00	0.25
Smooth Muscle Cells - Carotid, donor2	11362-117I3	6.12	6.12	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	4.77	0.95	0.48	1.43	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Colonic, donor1	11239-116D6	12.68	5.90	0.59	1.03	0.15	0.15	0.15	0.00
Smooth Muscle Cells - Colonic, donor2	11320-117D6	9.04	4.30	2.37	0.86	0.22	1.08	0.22	0.22
Smooth Muscle Cells - Colonic, donor3	11396-118D1	13.43	6.51	1.57	0.94	0.31	0.52	0.10	0.10
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	6.65	2.17	0.62	0.31	0.00	0.31	0.15	0.00
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	2.16	2.16	0.00	0.00	1.08	0.00	0.00	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	6.87	4.78	1.20	0.30	0.30	0.00	0.00	0.00
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	3.07	3.76	1.02	0.00	0.00	0.34	0.34	0.00
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	20.34	3.93	2.43	1.18	0.16	0.24	0.16	0.08
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	17.41	2.11	0.60	1.31	0.00	0.10	0.00	0.00
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	7.28	4.32	1.14	0.23	0.00	0.23	0.00	0.00
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	7.25	2.42	0.60	0.60	0.60	0.00	0.00	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	21.46	5.30	3.44	1.59	0.53	0.26	0.00	0.00
Smooth Muscle Cells - Prostate, donor1	11257-116F6	12.25	4.93	1.86	0.93	0.27	0.27	0.53	0.13
Smooth Muscle Cells - Prostate, donor2	11335-117F3	9.27	2.75	1.00	0.88	0.13	0.38	0.13	0.13
Smooth Muscle Cells - Prostate, donor3	11465-119B7	8.12	3.04	0.25	0.00	0.00	0.00	0.25	0.00
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	10.55	6.03	1.36	1.06	0.00	0.00	0.00	0.15
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	6.00	5.25	1.50	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	7.75	1.29	0.00	1.29	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	5.12	5.58	0.93	1.40	0.00	0.47	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	8.58	2.52	0.50	0.50	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	5.64	0.31	0.94	0.94	0.00	0.00	0.31	0.00
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	2.65	0.88	0.59	0.88	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	13.16	6.50	1.33	0.83	0.08	0.00	0.17	0.00
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	7.47	2.34	0.00	1.40	0.47	0.00	0.00	0.00
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	6.62	2.59	0.14	0.43	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	5.35	3.57	0.76	0.51	1.02	0.00	0.00	0.25
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	5.08	3.57	0.94	0.38	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	16.35	4.33	1.40	1.26	0.56	0.28	0.14	0.00
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	11.40	3.60	1.51	0.84	0.00	0.17	0.00	0.00
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	3.81	0.48	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	7.58	0.98	0.98	0.00	0.00	0.24	0.00	0.00
Smooth Muscle Cells - Uterine, donor1	11258-116F7	7.95	4.42	1.10	1.10	0.44	1.33	0.66	0.22
Smooth Muscle Cells - Uterine, donor3	11466-119B8	9.95	2.34	0.00	0.59	0.59	0.29	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	16.33	1.94	0.39	0.19	0.00	0.00	0.19	0.00
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	7.40	0.79	0.26	0.79	0.53	0.00	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	12.65	1.12	0.00	0.37	0.00	0.00	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	15.45	1.80	0.36	1.08	0.00	0.00	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	7.10	1.42	1.14	0.57	0.00	0.00	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	12.60	2.76	0.79	1.18	0.00	0.00	0.00	0.00
Smooth muscle cells - airway, control, donor1	11966-126D4	11.94	0.76	0.51	1.02	0.00	0.00	0.00	0.00
Smooth muscle cells - airway, control, donor2	11967-126D5	15.97	2.40	0.00	0.40	0.00	0.00	0.00	0.00
Smooth muscle cells - airway, control, donor3	11968-126D6	10.45	1.25	0.84	0.84	0.42	0.00	0.42	0.00
Smooth muscle cells - airway, control, donor4	11969-126D7	8.71	3.67	0.00	0.46	0.00	0.00	0.00	0.00
Synoviocyte, donor1	11291-117A4	18.18	5.39	0.50	1.35	0.50	0.17	0.00	0.00
Synoviocyte, donor2	11368-117I9	5.20	2.68	0.34	0.34	0.50	0.17	0.00	0.17
Synoviocyte, donor3	11440-118H9	6.93	2.46	0.00	0.89	0.00	0.22	0.22	0.00
Trabecular Meshwork Cells, donor1	11532-120A2	10.01	2.86	2.50	0.00	0.00	0.00	0.00	0.00
Trabecular Meshwork Cells, donor2	11612-122A1	5.95	1.98	0.00	0.00	0.00	0.00	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	9.26	1.16	0.46	0.46	0.00	0.23	0.00	0.00
Tracheal Epithelial Cells, donor1	11292-117A5	6.88	1.36	3.15	1.00	0.00	0.50	0.07	0.00
Tracheal Epithelial Cells, donor2	11369-118A1	2.71	2.71	1.93	1.16	1.16	0.39	0.00	0.39
Tracheal Epithelial Cells, donor3	11441-118I1	2.29	0.00	1.15	0.57	0.57	0.00	0.00	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	23.37	4.80	5.29	2.34	0.37	0.37	0.49	0.00
Urethra, donor2	10319-105A4	30.57	1.80	5.40	0.00	0.00	0.00	0.00	0.00
Urothelial Cells, donor1	11520-119H8	5.05	1.06	0.27	0.53	0.00	0.53	0.00	0.27
Urothelial Cells, donor2	11600-120H7	4.01	1.20	1.60	0.80	0.00	0.40	0.00	0.00
Urothelial Cells, donor3	11681-122H7	3.90	1.15	0.92	0.46	0.00	0.23	0.00	0.00
Urothelial cells, donor0	11216-116B1	21.40	2.01	6.24	2.90	0.00	0.67	0.00	0.22
Whole blood (ribopure), donor090309, donation1	12179-129A1	21.35	7.12	5.34	2.67	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	20.01	10.01	5.72	4.29	1.43	0.00	0.00	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	8.21	5.48	4.11	0.68	1.37	0.00	0.00	0.00
Whole blood (ribopure), donor090325, donation1	12176-128I7	17.56	7.92	7.58	1.72	0.00	0.00	0.34	0.34
Whole blood (ribopure), donor090325, donation2	12177-128I8	26.15	9.30	5.81	4.65	1.16	0.58	0.00	0.00
Whole blood (ribopure), donor090612, donation1	12182-129A4	22.91	11.45	5.21	0.00	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	20.19	9.18	4.59	0.92	0.92	0.00	0.00	0.92
Whole blood (ribopure), donor090612, donation3	12184-129A6	16.43	3.65	0.91	0.91	0.91	0.00	0.00	0.00
Wilms' tumor cell line:G-401	10809-111A8	11.72	5.92	3.08	1.60	0.49	0.25	0.12	0.25
Wilms' tumor cell line:HFWT	10597-108E3	13.20	1.76	1.76	3.52	0.00	0.00	0.00	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	18.16	1.96	7.54	1.12	0.00	0.56	0.00	0.00
achilles tendon, donor2	10292-104G4	12.40	8.27	0.00	0.00	0.00	0.00	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	21.67	12.49	5.35	1.02	0.76	0.25	0.25	0.25
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	27.16	16.95	3.02	0.70	0.93	0.00	0.00	0.00
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	25.40	12.46	12.23	3.44	0.59	0.95	0.12	0.47
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	29.12	13.61	5.44	1.09	1.09	0.00	0.27	0.00
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	2.25	5.62	0.28	0.00	4.50	0.00	0.00	0.00
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	11.84	19.67	1.48	1.06	5.08	0.00	0.21	0.42
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	13.07	17.97	3.81	1.91	6.81	0.00	0.54	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	5.29	7.93	0.44	0.00	3.97	0.44	0.44	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	11.84	12.25	2.04	2.04	2.45	0.41	0.00	0.00
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	14.76	20.19	0.78	0.78	3.11	0.00	0.00	0.39
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	8.65	5.70	2.76	0.74	0.18	0.00	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	23.40	15.60	7.80	3.90	3.90	0.00	3.90	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	15.34	14.87	1.16	0.93	5.58	0.23	0.00	0.00
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	25.63	9.32	3.11	2.07	1.29	0.26	0.26	0.26
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	23.67	7.01	0.58	0.58	0.58	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	21.84	6.97	3.72	0.46	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	23.03	8.64	2.88	1.23	0.82	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	19.03	3.38	0.92	1.53	0.92	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	17.92	6.83	1.28	2.56	0.85	0.00	0.43	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	24.57	7.89	1.21	3.64	0.61	0.30	0.61	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	28.64	7.46	2.65	2.17	0.00	0.48	0.48	0.00
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	36.53	14.03	2.23	1.78	1.78	0.45	0.00	0.22
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	20.01	5.67	3.34	4.34	1.00	0.33	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	35.31	7.43	1.86	1.86	1.86	0.00	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	19.59	15.44	1.13	1.88	3.77	0.00	0.00	0.00
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	14.39	14.39	2.62	0.44	9.59	0.00	0.00	1.31
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	29.99	13.12	1.87	1.87	5.62	1.87	1.87	0.00
adenocarcinoma cell line:IM95m	10796-110I4	28.50	4.24	3.77	2.12	0.00	0.94	0.00	0.00
adipose tissue, adult, pool1	10010-101C1	19.08	5.43	0.78	1.40	0.47	0.00	0.16	0.16
adipose, donor1	10184-103D4	54.54	14.07	8.21	7.62	0.00	0.00	1.17	0.00
adipose, donor2	10185-103D5	55.96	4.87	7.30	6.49	0.00	1.62	0.81	0.41
adipose, donor3	10186-103D6	37.58	9.26	8.17	5.45	0.00	1.36	0.27	0.54
adipose, donor4	10187-103D7	40.74	6.93	6.93	4.33	0.87	3.47	0.87	0.00
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	65.97	34.40	8.52	10.10	4.26	4.26	5.37	1.26
adrenal gland, adult, pool1	10081-102A9	0.00	0.00	0.00	3.64	0.00	0.00	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	29.88	3.34	7.87	2.27	0.27	0.53	0.00	0.27
alveolar cell carcinoma cell line:SW 1573	10708-109H6	18.58	7.86	5.72	1.43	0.71	1.07	0.00	0.00
amniotic membrane cells, donor1	12235-129G3	13.22	0.46	3.25	0.93	0.00	0.23	0.00	0.23
amniotic membrane cells, donor2	12236-129G4	15.21	4.40	1.69	2.70	0.34	0.68	0.34	0.00
amniotic membrane cells, donor3	12237-129G5	20.33	0.00	1.18	0.29	0.29	0.00	0.29	0.00
amygdala - adult, donor10196	10167-103B5	18.97	1.19	2.37	9.49	0.00	0.00	0.00	0.00
amygdala, adult, donor10252	10151-102I7	25.75	4.26	1.62	5.07	0.00	0.20	0.20	0.00
amygdala, newborn, donor10223	10360-105E9	22.27	1.61	1.94	7.42	0.00	0.65	0.00	0.00
anaplastic carcinoma cell line:8305C	10428-106D5	23.81	5.48	3.06	1.15	0.13	0.51	0.13	0.13
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	10.37	7.94	4.41	1.54	0.22	0.00	0.00	0.00
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	18.37	22.38	6.35	14.36	1.00	7.01	2.34	1.00
aorta, adult, pool1	10052-101G7	22.36	2.55	0.78	1.77	0.20	0.00	0.39	0.00
appendix, adult	10189-103D9	26.39	22.51	9.31	5.43	1.16	1.16	0.39	0.39
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	44.71	10.66	12.04	6.19	0.00	1.03	0.00	0.00
artery, adult	10190-103E1	40.76	5.43	9.51	9.51	0.00	1.36	0.00	2.72
astrocytoma cell line:TM-31	10425-106D2	31.44	13.91	7.53	4.06	0.14	2.03	0.43	0.14
b cell line:RPMI1788	10427-106D4	15.91	12.04	10.11	1.93	0.89	0.15	0.15	0.45
basal cell carcinoma cell line:TE 354.T	10702-109G9	15.54	2.50	0.00	0.28	0.00	0.00	0.28	0.28
bile duct carcinoma cell line:HuCCT1	10432-106D9	28.48	7.74	6.05	2.88	0.20	0.79	0.20	0.40
bile duct carcinoma cell line:TFK-1	10496-107C1	5.36	0.00	2.85	0.84	0.00	0.17	0.00	0.00
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	15.66	6.71	0.56	0.56	1.12	0.00	0.00	0.00
bladder, adult, pool1	10011-101C2	35.74	4.13	2.50	2.17	0.22	0.22	0.22	0.00
blood, adult, pool1	10053-101G8	8.86	0.00	2.21	2.21	0.00	2.21	0.00	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	10.28	6.85	0.00	0.00	0.00	0.00	0.00	0.00
bone marrow, adult	10192-103E3	41.16	10.80	2.02	2.02	0.00	0.00	0.00	0.00
brain, adult, donor1	10084-102B3	25.63	2.05	3.08	4.10	0.00	2.05	1.03	0.00
brain, adult, pool1	10012-101C3	23.16	3.23	4.12	3.01	0.11	0.11	0.11	0.00
brain, fetal, pool1	10085-102B4	13.36	5.34	2.67	8.01	0.00	2.67	0.00	0.00
breast carcinoma cell line:MCF7	10482-107A5	25.11	2.97	6.94	1.65	0.00	0.33	0.00	0.00
breast carcinoma cell line:MDA-MB-453	10419-106C5	28.46	2.75	12.36	2.50	0.12	0.75	0.00	0.37
breast, adult, donor1	10080-102A8	14.52	1.26	1.89	1.89	0.00	0.00	0.00	0.00
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	8.13	2.29	6.22	1.65	0.13	0.25	0.25	0.00
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	22.26	3.09	12.68	2.47	0.00	0.62	0.00	0.31
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	12.20	2.76	1.61	0.69	0.23	0.46	0.23	0.00
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	20.09	2.18	3.15	2.66	0.24	0.24	0.00	0.24
carcinoid cell line:NCI-H1770	10703-109H1	53.13	7.52	10.81	5.64	0.94	0.00	0.47	0.00
carcinoid cell line:NCI-H727	10735-110B6	46.38	6.13	20.24	3.72	0.44	1.42	0.11	0.44
carcinoid cell line:SK-PN-DW	10719-109I8	30.42	1.58	3.49	2.22	0.00	0.00	0.32	0.32
carcinosarcoma cell line:JHUCS-1	10642-109A3	96.36	20.23	11.18	5.32	0.53	0.53	1.33	0.53
caudate nucleus - adult, donor10196	10177-103C6	27.63	4.61	0.00	8.06	0.00	0.00	0.00	0.00
caudate nucleus, adult, donor10252	10164-103B2	18.91	2.68	3.18	4.02	0.00	0.67	0.17	0.17
caudate nucleus, adult, donor10258	10379-105H1	19.87	6.11	7.64	9.17	0.00	2.29	0.00	0.76
caudate nucleus, newborn, donor10223	10354-105E3	23.07	4.39	2.56	5.86	0.00	1.46	0.37	0.00
cerebellum - adult, donor10196	10173-103C2	37.87	14.57	8.74	5.83	0.00	0.00	0.00	0.00
cerebellum, adult, donor10252	10166-103B4	41.21	4.48	13.45	5.55	0.43	0.85	0.21	0.00
cerebellum, adult, pool1	10083-102B2	13.45	2.07	5.52	2.41	0.00	0.69	0.34	0.00
cerebellum, newborn, donor10223	10357-105E6	63.10	3.32	12.45	13.28	0.00	0.00	0.00	0.00
cerebral meninges, adult	10188-103D8	13.62	3.78	2.77	2.77	0.25	0.25	0.25	0.00
cerebrospinal fluid, donor2	10294-104G6	25.58	3.65	4.39	5.85	0.00	4.39	0.73	0.00
cervical cancer cell line:D98-AH2	10552-107I3	28.04	2.73	8.77	3.16	0.00	0.58	0.00	0.29
cervical cancer cell line:ME-180	10553-107I4	21.21	5.97	13.09	5.14	0.50	1.82	0.50	0.17
cervix, adult, pool1	10013-101C4	33.39	4.93	3.88	1.68	0.42	0.31	0.10	0.10
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	21.32	8.78	5.85	2.79	0.84	0.42	0.28	0.00
chondrosarcoma cell line:SW 1353	10700-109G7	32.66	7.84	0.00	1.31	0.00	0.00	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	11.06	0.87	3.23	0.50	0.00	0.12	0.00	0.00
choriocarcinoma cell line:SCH	10785-110H2	8.75	1.36	3.82	0.37	0.00	0.12	0.00	0.12
choriocarcinoma cell line:T3M-3	10618-108G6	20.40	1.19	3.79	1.19	0.00	0.71	0.00	0.00
chorionic membrane cells, donor1	12238-129G6	9.69	1.71	3.42	0.57	0.00	0.00	0.00	0.57
chorionic membrane cells, donor2	12239-129G7	17.30	7.16	3.08	1.09	0.00	0.40	0.20	0.00
chorionic membrane cells, donor3	12240-129G8	17.58	1.10	6.04	1.10	0.55	0.00	0.55	0.00
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	3.03	9.09	2.02	0.00	1.01	0.00	0.00	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	10.37	17.29	1.54	0.77	9.80	0.38	0.19	0.00
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	12.04	12.46	4.01	1.69	0.42	0.42	0.00	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	25.42	4.11	14.38	3.85	0.26	0.77	0.00	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	19.83	5.56	15.00	3.39	0.00	1.69	0.00	0.97
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	18.94	4.68	12.42	5.90	0.41	1.02	0.20	0.00
chronic myelogenous leukemia cell line:K562	10454-106G4	12.37	5.59	6.77	1.77	0.00	0.88	0.00	0.00
chronic myelogenous leukemia cell line:KU812	10409-106B4	28.41	13.29	4.69	2.35	0.78	0.78	0.52	0.00
clear cell carcinoma cell line:JHOC-5	10638-108I8	42.74	16.23	5.03	5.49	0.00	2.29	0.46	0.00
clear cell carcinoma cell line:TEN	10636-108I6	24.98	3.99	4.16	2.26	0.17	0.52	0.00	0.17
colon carcinoma cell line:CACO-2	10513-107D9	19.40	8.97	6.41	2.01	0.18	0.92	0.18	0.18
colon carcinoma cell line:COLO-320	10420-106C6	80.96	13.30	20.14	2.28	0.00	0.00	0.38	0.00
colon, adult, donor1	10082-102B1	24.99	4.76	8.33	1.19	2.38	2.38	0.00	0.00
colon, adult, pool1	10014-101C5	35.60	6.82	7.87	3.17	1.06	0.94	0.12	0.35
colon, fetal, donor1	10070-101I7	31.52	6.80	6.80	4.33	1.24	1.24	0.00	0.00
common myeloid progenitor CMP, donor1	12130-128D6	50.42	91.67	4.58	0.00	4.58	4.58	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	10.20	13.17	9.35	1.70	2.55	2.97	0.42	0.00
cord blood derived cell line:COBL-a 24h infection	10453-106G3	6.94	14.79	3.17	2.57	1.21	0.75	0.15	0.30
cord blood derived cell line:COBL-a untreated	10449-106F8	8.18	16.92	4.37	2.96	1.97	0.56	0.85	0.14
corpus callosum, adult, pool1	10042-101F6	63.68	7.63	3.54	3.65	0.55	0.22	0.22	0.00
cruciate ligament, donor2	10295-104G7	15.40	5.67	0.00	1.62	0.00	0.00	0.00	0.00
diaphragm, fetal, donor1	10069-101I6	31.30	7.22	1.61	7.22	0.00	1.61	0.00	1.61
diencephalon, adult	10193-103E4	23.04	2.64	1.92	3.36	0.48	0.24	0.24	0.48
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	16.76	6.43	2.76	1.15	0.46	0.00	0.00	0.00
ductal cell carcinoma cell line:KLM-1	10438-106E6	36.16	5.90	15.13	5.13	0.00	0.77	0.26	0.00
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	17.09	3.85	3.37	0.96	0.00	1.20	0.96	0.48
ductus deferens, adult	10196-103E7	26.91	1.99	4.98	0.50	0.50	0.00	0.00	0.00
duodenum, fetal, donor1, tech_rep1	10071-101I8	25.92	8.64	7.20	2.88	1.44	0.00	1.44	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	54.44	5.89	4.41	6.62	0.74	0.74	0.00	0.74
dura mater, adult, donor1	10041-101F5	27.09	13.30	3.14	1.24	1.40	0.17	0.08	0.00
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	22.65	15.10	12.44	3.11	1.11	2.00	1.33	2.44
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	45.57	11.32	16.48	4.01	0.43	1.43	0.57	1.72
embryonic pancreas cell line:1B2C6	10604-108F1	15.42	3.08	2.47	1.23	0.00	1.23	0.00	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	17.25	2.72	3.03	2.72	0.30	0.30	0.00	0.00
embryonic pancreas cell line:1C3IKEI	10606-108F3	16.98	3.09	2.16	0.93	0.00	0.31	0.31	0.00
embryonic pancreas cell line:2C6	10603-108E9	21.02	0.00	1.31	0.00	0.00	0.00	0.00	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	14.41	0.67	4.02	1.68	0.00	0.34	0.00	0.00
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	27.37	3.08	1.27	0.54	0.00	0.18	0.00	0.00
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	29.11	4.82	1.77	2.73	0.16	0.48	0.16	0.16
epidermoid carcinoma cell line:A431	10426-106D3	26.23	3.89	11.12	2.22	0.44	1.56	0.11	0.33
epidermoid carcinoma cell line:Ca Ski	10431-106D8	36.19	12.76	14.63	5.39	0.77	2.42	0.33	0.66
epididymis, adult	10197-103E8	27.63	7.12	10.67	5.02	0.84	1.26	0.00	0.00
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	20.22	6.56	3.73	1.42	0.35	0.35	0.71	0.00
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	8.26	0.79	2.36	0.79	0.00	0.00	0.39	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	29.22	8.13	18.74	3.28	1.18	1.83	0.52	0.39
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	34.45	8.27	20.67	3.35	0.59	0.89	0.39	0.39
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	32.60	8.40	16.80	3.70	0.56	1.57	0.22	0.22
esophagus, adult, pool1	10015-101C6	27.39	3.82	3.82	1.27	0.32	0.11	0.00	0.00
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	35.32	25.42	10.90	8.27	4.51	1.88	3.88	3.13
eye - muscle inferior rectus, donor1	10272-104E2	41.05	0.00	7.24	2.41	0.00	0.00	0.00	0.00
eye - muscle lateral, donor2	10298-104H1	48.40	10.52	6.31	2.10	0.00	2.10	0.00	0.00
eye - muscle medial, donor2	10299-104H2	22.32	1.49	0.00	1.49	0.00	0.00	0.00	0.00
eye - muscle superior, donor2	10297-104G9	22.93	2.29	1.15	3.44	0.00	0.00	1.15	0.00
eye - vitreous humor, donor1	10268-104D7	8.74	2.91	10.20	1.46	1.46	0.00	0.00	0.00
eye, fetal, donor1	10054-101G9	19.07	4.32	4.07	2.03	0.25	0.25	0.51	0.00
fibrosarcoma cell line:HT-1080	10758-110E2	17.95	6.54	2.82	1.03	0.00	0.51	0.00	0.00
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	14.96	6.89	1.66	0.95	0.00	0.00	0.24	0.00
frontal lobe, adult, pool1	10040-101F4	29.74	4.69	5.07	6.66	0.19	0.56	0.09	0.09
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	38.13	7.81	10.21	3.60	0.00	0.30	0.30	0.60
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	35.84	5.76	7.41	3.84	0.27	0.91	0.18	0.18
gall bladder, adult	10198-103E9	20.28	5.31	4.59	1.21	0.00	0.24	0.00	0.00
gamma delta positive T cells, donor1	11937-126A2	20.40	15.57	3.22	3.22	2.15	0.00	0.00	0.00
gamma delta positive T cells, donor2	11938-126A3	10.83	14.57	5.23	1.49	1.87	0.00	0.00	0.00
gastric adenocarcinoma cell line:MKN1	10614-108G2	16.69	3.80	7.18	4.44	0.00	2.53	0.00	0.21
gastric adenocarcinoma cell line:MKN45	10612-108F9	34.04	4.45	7.74	4.84	0.19	0.00	0.00	0.00
gastric cancer cell line:AZ521	10549-107H9	27.22	8.36	3.61	1.97	0.16	0.16	0.33	0.00
gastric cancer cell line:GSS	10560-108A2	40.27	7.32	5.49	4.58	0.00	0.00	0.00	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	19.65	6.85	7.31	3.43	0.23	1.83	0.00	0.23
giant cell carcinoma cell line:LU65	10487-107B1	9.87	0.80	3.90	1.95	0.00	0.92	0.00	0.00
giant cell carcinoma cell line:Lu99B	10433-106E1	13.58	4.34	5.18	1.26	0.14	0.00	0.28	0.00
glassy cell carcinoma cell line:HOKUG	10688-109F4	17.46	5.24	13.72	3.99	0.50	0.50	0.00	0.50
glioblastoma cell line:A172, tech_rep1	10444-106F3	24.80	12.56	6.54	1.90	0.74	0.42	0.42	0.21
glioblastoma cell line:A172, tech_rep2	10444-106F3	21.07	11.24	6.88	2.81	0.56	0.28	0.56	0.28
glioblastoma cell line:T98G	10485-107A8	21.96	13.13	3.64	1.32	0.88	0.11	0.55	0.11
glioma cell line:GI-1	10413-106B8	16.99	7.61	5.56	0.59	1.17	0.29	0.00	0.00
globus pallidus - adult, donor10196	10175-103C4	25.51	4.37	1.46	5.10	0.00	0.73	0.00	0.00
globus pallidus, adult, donor10252	10161-103A8	40.52	3.91	1.46	4.39	0.49	0.00	0.24	0.00
globus pallidus, adult, donor10258	10367-105F7	38.34	2.74	2.74	4.11	0.00	0.00	0.00	0.00
globus pallidus, newborn, donor10223	10364-105F4	23.45	2.66	1.07	3.20	0.00	0.53	0.00	0.53
granulocyte macrophage progenitor, donor1	12131-128D7	46.50	115.02	9.79	0.00	14.68	0.00	0.00	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	43.71	10.93	0.00	0.00	10.93	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	5.23	0.00	0.00	0.00	0.00	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	30.08	6.08	3.84	1.92	0.96	0.32	0.32	0.00
hIPS +CCl2, biol_rep1	14383-156B9	74.38	15.15	5.05	6.89	0.46	4.13	2.75	0.46
hIPS +CCl2, biol_rep2	14384-156C1	73.16	14.18	10.97	6.40	0.46	5.49	3.66	1.37
hIPS +CCl2, biol_rep3	14385-156C2	79.87	14.81	6.44	7.09	0.00	3.22	1.93	0.00
hIPS, biol_rep1	14380-156B6	76.18	11.50	2.87	11.50	1.44	7.19	0.00	0.00
hIPS, biol_rep2	14381-156B7	72.02	17.15	6.86	7.54	0.69	3.43	1.37	0.00
hIPS, biol_rep3	14382-156B8	27.59	4.41	5.52	6.62	0.00	1.10	0.00	1.10
hairy cell leukemia cell line:Mo	10712-109I1	11.49	6.90	3.74	3.74	1.44	0.57	0.00	0.29
heart - mitral valve, adult	10205-103F7	26.01	9.57	2.09	2.09	0.00	0.60	0.60	0.00
heart - pulmonic valve, adult	10206-103F8	24.84	4.71	2.88	1.05	1.05	0.00	0.00	0.00
heart - tricuspid valve, adult	10207-103F9	20.82	9.99	0.00	1.67	0.83	0.00	0.00	0.83
heart, adult, diseased post-infarction, donor1	10050-101G5	17.96	4.08	2.86	1.22	0.20	0.20	0.00	0.00
heart, adult, diseased, donor1	10051-101G6	25.98	1.70	3.41	2.98	0.00	0.00	0.00	0.00
heart, adult, pool1	10016-101C7	14.72	5.06	2.53	1.15	0.23	0.00	0.00	0.00
heart, fetal, pool1	10046-101G1	36.76	14.48	7.70	3.29	0.82	0.62	0.10	0.00
hepatic mesenchymal tumor cell line:LI90	10778-110G4	16.35	7.40	0.93	2.47	0.31	1.85	0.00	0.31
hepatoblastoma cell line:HuH-6	10633-108I3	34.49	1.19	0.00	1.19	0.00	0.00	0.00	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	15.69	4.64	8.51	1.66	0.11	1.10	0.11	0.22
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	18.08	5.70	8.62	1.94	0.12	0.97	0.24	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	19.81	6.37	8.69	2.32	0.40	0.81	0.30	0.10
hepatoma cell line:Li-7	10484-107A7	18.46	5.34	6.78	1.22	0.33	0.22	0.22	0.22
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	16.28	9.75	8.94	2.21	0.70	0.70	0.30	0.50
hippocampus - adult, donor10196	10169-103B7	30.28	0.95	3.79	6.62	0.00	0.95	0.00	0.00
hippocampus, adult, donor10252	10153-102I9	24.90	4.08	3.27	5.51	0.00	0.41	0.00	0.00
hippocampus, adult, donor10258	10374-105G5	23.40	5.48	2.99	10.46	0.00	0.00	0.50	0.00
hippocampus, newborn, donor10223	10363-105F3	26.44	2.82	0.35	9.52	0.00	0.70	0.35	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	65.31	9.16	3.05	3.05	0.00	4.88	0.61	0.61
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	51.25	7.27	5.50	5.30	0.20	1.57	1.37	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	59.67	8.89	4.57	5.08	0.51	1.27	1.02	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	45.67	10.15	11.84	3.38	0.56	0.56	0.56	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	39.51	6.20	7.23	3.36	0.26	1.81	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	36.82	9.11	6.45	3.80	0.38	1.14	0.76	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	54.01	11.39	8.47	4.96	0.29	2.04	0.58	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	32.53	9.91	8.62	5.17	0.86	1.08	1.51	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	41.71	12.93	10.84	3.34	1.25	1.25	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	16.81	7.81	4.03	1.89	0.00	0.24	0.71	0.24
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	26.84	10.13	5.14	4.50	0.32	1.61	1.45	0.16
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	20.20	8.75	6.06	4.04	0.00	0.00	2.02	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	57.12	7.82	4.69	5.16	0.78	1.56	1.72	0.63
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	64.85	6.88	7.86	7.37	0.49	1.47	1.47	0.49
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	72.44	8.73	11.35	7.85	0.00	2.62	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	46.01	11.07	9.93	4.20	0.38	1.91	0.38	0.19
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	39.25	13.95	9.16	4.36	1.31	2.62	0.44	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	61.97	7.50	7.00	7.50	0.00	1.50	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	46.34	8.10	12.43	2.64	0.00	0.57	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	45.47	6.37	10.91	6.82	0.45	0.00	1.36	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	49.49	6.89	9.08	5.33	0.31	0.31	0.31	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	21.39	5.23	7.19	3.92	0.00	0.33	0.82	0.16
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	21.48	4.94	7.26	3.77	0.29	0.58	1.16	0.29
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	26.60	5.68	9.86	5.98	0.60	1.20	0.30	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	50.25	9.42	5.91	6.65	0.37	2.03	2.40	0.92
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	51.92	7.70	4.28	4.85	0.29	2.57	0.86	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	55.53	8.57	8.57	6.94	0.41	2.04	0.82	1.63
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	40.49	10.91	4.93	3.17	0.00	0.70	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	38.96	7.60	5.70	4.12	0.63	1.58	0.32	0.32
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	36.01	6.96	5.75	3.93	0.91	0.30	0.00	0.30
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	23.27	5.69	4.14	3.62	1.03	0.52	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	22.58	8.63	5.98	8.63	1.33	0.00	0.66	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	25.14	7.44	5.39	3.59	0.00	0.77	0.77	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	20.71	7.93	4.86	3.32	0.51	0.77	0.77	0.26
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	20.45	8.33	6.82	5.30	1.51	1.51	2.27	0.76
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	22.18	8.74	5.04	3.02	0.67	0.67	0.00	0.67
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	67.62	11.83	6.76	8.45	0.24	4.35	2.66	0.72
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	74.43	12.92	8.47	9.36	0.89	4.90	1.34	1.34
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	72.68	10.24	7.80	12.20	0.49	4.39	1.46	0.98
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	34.84	10.39	5.20	3.67	0.61	0.92	0.31	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	117.12	26.03	6.51	9.76	3.25	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	36.40	8.60	7.61	4.96	0.66	1.99	0.33	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	37.22	9.85	6.02	3.28	0.55	1.09	0.55	0.55
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	38.36	4.34	7.24	2.53	0.72	1.45	0.36	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	38.79	7.12	6.41	6.41	1.42	1.07	0.36	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	33.41	7.16	7.16	3.58	0.00	2.39	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	40.63	15.17	8.67	3.52	1.08	0.54	0.95	0.14
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	22.36	6.47	4.85	3.77	0.27	0.54	0.54	0.27
immature langerhans cells, donor1	11904-125F5	14.29	8.96	3.15	2.91	2.42	0.73	0.24	0.73
immature langerhans cells, donor2	11905-125F6	23.76	7.13	3.17	7.13	0.79	1.58	0.00	0.00
insula, adult, pool1	10039-101F3	32.08	4.73	5.96	9.37	0.28	0.85	0.19	0.09
keratoacanthoma cell line:HKA-1	10791-110H8	10.40	3.25	11.06	2.93	0.65	0.98	0.00	0.00
kidney, adult, pool1	10017-101C8	23.33	6.71	3.80	2.50	0.40	0.80	0.00	0.10
kidney, fetal, pool1	10045-101F9	36.57	13.02	7.36	4.10	0.21	0.57	0.35	0.21
large cell lung carcinoma cell line:IA-LM	10509-107D5	19.46	4.97	1.56	0.85	0.00	0.00	0.14	0.00
large cell lung carcinoma cell line:NCI-H460	10839-111E2	14.93	3.04	6.64	1.24	0.00	0.00	0.00	0.14
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	25.69	4.22	4.04	2.94	0.37	1.10	0.18	0.18
left atrium, adult, donor1	10079-102A7	16.35	1.09	1.63	1.09	1.09	0.54	0.00	0.00
left ventricle, adult, donor1	10078-102A6	17.70	4.05	3.54	1.01	0.00	0.51	0.00	0.00
leiomyoblastoma cell line:G-402	10721-110A1	14.77	3.83	1.92	3.01	0.00	0.00	0.55	0.00
leiomyoma cell line:10964C	10569-108B2	3.23	1.08	0.72	0.72	0.00	0.36	0.36	0.36
leiomyoma cell line:15242A	10570-108B3	7.61	0.00	0.00	0.00	0.00	0.00	0.54	0.00
leiomyoma cell line:15425	10571-108B4	10.68	2.19	0.49	0.97	0.24	0.24	0.00	0.00
leiomyosarcoma cell line:Hs 5.T	10722-110A2	0.00	12.70	0.00	0.00	0.00	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	21.96	7.32	8.36	5.23	2.09	2.09	0.00	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	11.45	6.26	2.83	1.18	0.35	0.35	0.00	0.00
liposarcoma cell line:KMLS-1	10782-110G8	20.93	11.25	4.06	2.03	1.09	0.47	0.16	0.31
liposarcoma cell line:SW 872	10726-110A6	18.40	8.77	4.63	1.83	0.37	0.49	0.12	0.00
liver, adult, pool1	10018-101C9	22.69	4.21	4.38	1.78	0.00	0.32	0.16	0.00
liver, fetal, pool1	10086-102B5	10.35	1.88	0.94	0.00	0.00	0.00	0.00	0.00
locus coeruleus - adult, donor10196	10182-103D2	26.83	2.48	2.19	1.31	0.00	0.29	0.00	0.15
locus coeruleus, adult, donor10252	10165-103B3	23.62	4.24	2.21	1.66	0.18	0.37	0.18	0.00
locus coeruleus, adult, donor10258	10375-105G6	23.14	2.82	2.54	2.54	0.56	0.28	0.00	0.28
locus coeruleus, newborn, donor10223	10362-105F2	19.77	2.52	4.21	5.47	0.42	0.42	0.00	0.00
lung adenocarcinoma cell line:A549	10499-107C4	14.95	2.77	5.54	0.97	0.00	0.42	0.00	0.00
lung adenocarcinoma cell line:PC-14	10408-106B3	19.30	2.76	1.38	0.69	0.00	0.00	0.00	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	26.76	5.80	6.06	2.64	0.66	1.45	0.40	0.26
lung, adult, pool1	10019-101D1	26.93	4.84	1.89	1.06	0.47	0.12	0.00	0.00
lung, fetal, donor1	10068-101I5	146.70	25.12	11.70	11.13	1.14	2.00	0.86	0.29
lung, right lower lobe, adult, donor1	10075-102A3	28.41	5.96	2.29	4.58	0.92	0.46	0.00	0.00
lymph node, adult, donor1	10077-102A5	12.78	6.63	1.89	1.89	0.00	0.00	0.00	0.00
lymphangiectasia cell line:DS-1	10727-110A7	15.56	4.82	3.07	1.32	0.22	0.00	0.00	0.00
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	38.49	35.17	22.34	3.17	2.57	1.21	0.30	0.15
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	16.99	5.95	11.89	3.40	0.00	0.00	0.00	0.85
mature adipocyte, donor1	12231-129F8	12.43	2.22	0.44	0.44	0.44	0.00	0.44	0.00
mature adipocyte, donor2	12232-129F9	14.94	5.40	0.62	0.42	0.00	0.21	0.00	0.21
mature adipocyte, donor3	12233-129G1	13.28	6.40	0.47	0.24	0.00	0.00	0.00	0.00
mature adipocyte, donor4	12234-129G2	19.74	5.26	0.26	0.00	0.26	0.00	0.53	0.00
maxillary sinus tumor cell line:HSQ-89	10414-106B9	56.23	4.29	15.49	2.14	0.24	0.00	0.24	0.00
medial frontal gyrus - adult, donor10196	10170-103B8	20.30	2.26	5.64	3.38	0.00	1.13	0.00	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	24.46	2.21	2.21	5.15	0.00	0.18	0.18	0.00
medial frontal gyrus, adult, donor10258	10368-105F8	23.51	3.81	3.18	4.45	0.32	0.32	0.00	0.00
medial frontal gyrus, newborn, donor10223	10352-105E1	28.57	1.71	0.85	10.66	0.00	0.43	0.43	0.00
medial temporal gyrus - adult, donor10196	10183-103D3	28.86	1.86	3.71	7.43	0.51	0.51	0.17	0.34
medial temporal gyrus, adult, donor10252	10156-103A3	26.95	4.03	2.33	5.09	0.00	0.64	0.42	0.21
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	15.41	1.93	3.85	7.71	0.00	0.00	0.00	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	14.35	43.06	0.00	14.35	0.00	0.00	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	26.56	2.87	1.44	5.74	0.36	1.79	0.36	0.00
medulla oblongata - adult, donor10196	10174-103C3	22.07	1.30	3.24	2.60	0.00	0.65	1.30	0.00
medulla oblongata, adult, donor10252	10155-103A2	24.92	4.02	2.32	3.25	0.15	0.62	0.46	0.15
medulla oblongata, adult, pool1	10038-101F2	35.67	6.37	4.24	3.75	0.49	0.33	0.49	0.16
medulla oblongata, newborn, donor10223	10361-105F1	18.75	3.12	1.04	1.04	0.35	0.00	0.00	0.00
medulloblastoma cell line:D283 Med	10838-111E1	40.08	6.64	12.62	1.11	0.44	0.66	0.89	0.00
medulloblastoma cell line:ONS-76	10759-110E3	18.71	9.54	4.65	1.10	0.37	0.37	0.24	0.24
melanoma cell line:COLO 679	10514-107E1	25.30	7.04	3.88	1.72	0.29	1.29	0.14	0.43
melanoma cell line:G-361	10465-106H6	16.56	8.69	3.53	2.44	0.27	0.27	0.00	0.00
meningioma cell line:HKBMM	10691-109F7	9.23	1.45	3.44	1.63	0.00	0.36	0.00	0.00
merkel cell carcinoma cell line:MKL-1	10843-111E6	45.82	17.62	13.22	7.93	1.76	3.52	1.76	0.00
merkel cell carcinoma cell line:MS-1	10844-111E7	36.03	12.96	8.81	5.44	0.78	2.07	0.52	0.78
mesenchymal precursor cell - adipose, donor1	11747-123G1	8.29	8.75	0.61	0.61	0.31	0.15	0.00	0.00
mesenchymal precursor cell - adipose, donor2	11748-123G2	5.27	2.36	0.36	0.73	0.18	0.18	0.00	0.00
mesenchymal precursor cell - adipose, donor3	11749-123G3	9.94	2.48	1.66	0.83	0.00	0.00	0.41	0.00
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	7.02	4.64	0.70	0.00	0.14	0.14	0.28	0.00
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	7.13	2.89	0.39	0.77	0.00	0.19	0.00	0.19
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	9.02	6.25	0.69	0.00	0.00	0.00	0.00	0.00
mesenchymal precursor cell - cardiac, donor1	11752-123G6	6.01	1.03	0.34	0.17	0.00	0.00	0.00	0.00
mesenchymal precursor cell - cardiac, donor2	11753-123G7	6.90	2.99	1.04	0.69	0.12	0.23	0.12	0.12
mesenchymal precursor cell - cardiac, donor3	11754-123G8	7.16	4.64	1.33	1.06	0.27	0.27	0.00	0.00
mesenchymal precursor cell - cardiac, donor4	11755-123G9	8.64	7.83	1.49	0.95	0.27	0.54	0.14	0.14
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	10.53	5.98	1.42	1.00	0.28	0.71	0.57	0.28
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	10.21	3.29	0.33	0.00	0.66	0.00	0.33	0.33
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	9.69	8.03	1.52	1.80	0.83	0.28	0.42	0.14
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	15.71	5.93	1.75	1.75	0.00	0.35	0.35	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	5.72	5.10	1.43	2.25	0.41	0.00	0.00	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	11.14	2.88	1.08	2.52	0.36	0.00	0.00	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	12.93	2.48	1.55	1.24	0.10	0.00	0.00	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	6.61	3.42	0.00	1.60	0.23	0.68	0.00	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	17.20	5.87	0.84	3.36	0.00	0.84	0.00	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	11.96	6.13	1.64	0.60	0.45	0.30	0.00	0.15
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	10.07	4.38	1.23	1.14	0.18	0.35	0.53	0.44
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	13.62	5.52	1.47	0.37	0.00	0.37	0.00	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	10.02	6.87	1.72	1.72	0.57	0.57	0.00	0.00
mesenchymal stem cell line:Hu5/E18	10568-108B1	21.47	7.16	1.26	1.68	0.00	0.00	0.42	0.42
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	5.94	4.57	0.46	0.91	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	9.98	3.84	0.51	1.02	0.26	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	9.16	4.71	1.31	1.83	0.00	0.26	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	14.48	4.31	0.62	1.23	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	8.00	3.29	0.71	0.47	0.24	0.00	0.24	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	7.11	3.72	2.37	0.00	0.00	0.68	0.34	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	8.25	1.96	1.57	0.39	0.00	0.39	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	9.27	4.63	0.93	1.39	0.46	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	11.54	2.02	1.44	1.15	0.29	0.29	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	7.81	3.35	1.34	1.12	0.45	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	8.89	3.85	0.72	0.48	0.00	0.24	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	15.40	5.87	1.47	0.00	0.00	0.00	0.73	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	9.40	4.03	1.01	1.68	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	6.55	4.50	1.23	0.41	0.00	0.41	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	12.03	1.72	1.29	0.00	0.43	0.00	0.43	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	5.47	0.00	2.73	2.73	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	5.16	5.16	0.00	5.16	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	10.07	2.92	0.97	0.65	0.00	0.65	0.32	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	8.73	2.91	0.00	1.45	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	9.06	2.67	2.13	0.53	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	8.18	3.27	0.00	0.82	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	5.44	2.72	1.17	0.39	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	4.20	2.10	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	2.98	2.98	0.99	0.00	0.00	0.00	0.00	0.99
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	14.30	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	8.89	2.96	0.59	1.78	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	7.31	1.22	0.00	1.22	1.22	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	3.80	1.90	1.27	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	8.62	4.48	1.03	0.69	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	10.75	4.30	0.00	2.15	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	3.99	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	3.44	3.44	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	4.89	2.44	0.00	0.41	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	6.36	2.38	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	7.07	4.13	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	4.68	1.56	0.00	0.00	0.00	0.00	0.00	0.31
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	5.35	1.34	1.34	0.00	1.34	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	4.73	3.55	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	2.57	2.57	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	8.95	4.13	0.00	1.38	0.69	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	6.93	2.47	0.49	0.49	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	13.46	2.24	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	8.27	1.27	0.64	0.64	0.00	0.00	0.64	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	8.06	1.61	0.00	0.40	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	2.18	2.18	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	3.80	1.27	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	7.89	0.61	1.21	0.61	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	9.06	0.00	0.00	0.82	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	7.34	2.78	0.00	0.40	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	5.84	2.27	0.00	0.65	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	7.13	4.07	0.00	1.02	0.00	0.00	0.00	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	29.40	3.87	0.77	2.32	0.77	0.00	0.77	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	47.25	6.61	4.02	2.36	0.00	1.65	0.71	0.71
mesothelioma cell line:ACC-MESO-4	10494-107B8	11.82	7.18	7.88	2.55	0.23	0.70	0.23	0.23
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	21.37	17.09	4.27	0.00	4.27	0.00	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	20.24	6.68	2.36	1.34	0.10	0.21	0.00	0.00
mesothelioma cell line:Mero-25	10850-111F4	6.81	2.95	3.40	0.45	0.00	0.23	0.23	0.00
mesothelioma cell line:Mero-41	10851-111F5	28.11	7.58	6.36	2.20	0.98	0.49	0.00	0.00
mesothelioma cell line:Mero-48a	10852-111F6	20.15	6.42	4.87	1.77	0.00	0.89	0.22	0.00
mesothelioma cell line:Mero-82	10853-111F7	11.83	3.15	3.15	1.84	0.26	1.05	0.26	0.53
mesothelioma cell line:Mero-83	10854-111F8	19.06	8.17	4.94	2.04	0.51	0.68	0.34	0.34
mesothelioma cell line:Mero-84	10855-111F9	16.18	8.09	2.53	1.26	0.51	0.00	0.25	0.00
mesothelioma cell line:Mero-95	10856-111G1	10.77	3.31	5.59	1.04	0.00	0.41	0.00	0.21
mesothelioma cell line:NCI-H2052	10847-111F1	13.25	3.64	1.66	0.66	0.33	0.33	0.17	0.17
mesothelioma cell line:NCI-H226	10846-111E9	4.89	5.79	4.16	0.72	0.18	0.18	0.00	0.36
mesothelioma cell line:NCI-H2452	10848-111F2	15.54	5.30	4.44	2.05	0.17	0.17	0.17	0.00
mesothelioma cell line:NCI-H28	10845-111E8	13.74	3.56	3.05	1.02	0.00	0.00	0.00	0.25
mesothelioma cell line:No36	10857-111G2	36.53	6.20	5.87	4.89	0.33	0.33	0.33	0.65
mesothelioma cell line:ONE58	10858-111G3	15.17	1.90	2.98	1.35	0.00	0.81	0.00	0.00
migratory langerhans cells, donor1	11901-125F2	25.72	5.95	2.30	3.84	0.58	0.58	0.38	0.00
migratory langerhans cells, donor2	11902-125F3	20.39	10.14	4.15	3.79	1.10	0.73	0.24	0.49
migratory langerhans cells, donor3	11903-125F4	25.49	11.85	5.20	2.15	1.79	0.00	0.18	0.18
mixed mullerian tumor cell line:HTMMT	10689-109F5	37.22	3.26	2.61	3.59	0.33	0.65	0.00	0.00
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	8.48	0.64	1.70	0.21	0.21	0.00	0.00	0.00
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	18.43	1.38	4.38	1.84	0.00	0.00	0.00	0.00
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	4.76	8.18	1.52	2.09	0.76	0.76	0.00	0.00
myelodysplastic syndrome cell line:SKM-1	10772-110F7	28.46	10.72	2.77	1.48	0.74	0.00	0.18	0.18
myeloma cell line:PCM6	10474-106I6	12.65	1.98	2.97	0.40	0.00	0.00	0.00	0.00
myxofibrosarcoma cell line:MFH-ino	10600-108E6	39.06	8.12	1.52	2.03	0.00	1.01	0.00	0.00
myxofibrosarcoma cell line:NMFH-1	10684-109E9	12.16	6.08	2.35	0.78	0.59	0.98	0.20	0.00
nasal epithelial cells, donor1, tech_rep1	12226-129F3	11.48	0.22	1.56	0.89	0.00	0.11	0.00	0.00
nasal epithelial cells, donor1, tech_rep2	12226-129F3	10.08	0.29	1.69	0.88	0.07	0.15	0.00	0.07
nasal epithelial cells, donor2	12227-129F4	11.04	2.21	3.31	0.55	0.55	0.00	0.00	0.00
neuroblastoma cell line:CHP-134	10508-107D4	30.37	13.34	11.27	2.99	0.23	0.69	0.69	0.69
neuroblastoma cell line:NB-1	10539-107G8	23.76	19.46	6.74	1.31	0.75	0.37	0.56	0.19
neuroblastoma cell line:NBsusSR	10607-108F4	9.28	5.69	9.49	0.84	0.00	0.63	0.84	0.84
neuroblastoma cell line:NH-12	10555-107I6	37.46	11.93	9.88	1.12	0.56	0.19	0.37	0.19
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	25.38	4.03	3.08	0.47	0.00	0.24	0.00	0.00
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	22.33	7.29	2.69	5.23	0.79	0.63	0.32	0.00
neuroectodermal tumor cell line:TASK1	10774-110F9	27.17	6.64	3.22	0.81	0.20	0.20	0.00	0.00
neuroepithelioma cell line:SK-N-MC	10728-110A8	30.52	3.81	1.91	0.64	0.00	0.00	0.00	0.64
neurofibroma cell line:Hs 53.T	10729-110A9	18.90	6.92	1.86	0.53	0.53	0.53	0.00	0.27
neutrophil PMN, donor1	12133-128D9	0.00	59.50	0.00	0.00	14.87	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	13.28	0.00	0.00	0.00	0.00	0.00	13.28	0.00
neutrophil PMN, donor3	12141-128E8	0.00	9.47	0.00	0.00	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	14.38	21.14	2.71	1.18	2.20	0.00	0.17	0.17
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	20.81	6.40	3.20	0.80	0.00	0.80	0.00	0.80
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	9.30	4.49	0.64	1.60	0.32	0.32	0.00	0.00
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	11.56	7.09	0.79	1.31	0.53	0.53	0.00	0.00
nucleus accumbens, adult, pool1	10037-101F1	32.43	5.91	4.50	7.12	0.37	0.84	0.19	0.19
occipital cortex - adult, donor10196	10172-103C1	30.91	2.06	6.18	8.24	0.00	0.00	0.00	0.00
occipital cortex, adult, donor10252	10163-103B1	31.94	3.76	1.88	4.03	0.00	0.27	0.27	0.27
occipital cortex, newborn, donor10223	10355-105E4	20.02	2.18	1.82	10.92	0.00	0.73	0.00	0.00
occipital lobe, adult, donor1	10076-102A4	23.88	3.94	7.08	6.30	0.26	1.05	0.26	0.00
occipital lobe, fetal, donor1	10073-102A1	30.90	9.01	2.15	2.57	0.00	0.43	1.72	0.00
occipital pole, adult, pool1	10036-101E9	25.78	4.73	6.07	5.05	0.24	0.47	0.24	0.24
olfactory region, adult	10195-103E6	22.35	3.82	2.48	4.20	0.00	0.57	0.19	0.19
optic nerve, donor1	10277-104E7	56.03	2.00	0.00	10.01	0.00	0.00	0.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	14.47	2.62	10.48	2.05	0.11	0.57	0.11	0.34
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	16.49	1.51	4.53	1.37	0.00	0.27	0.14	0.00
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	10.84	3.05	2.71	1.35	0.00	0.68	0.00	0.00
oral squamous cell carcinoma cell line:SAS	10544-107H4	22.29	9.01	17.67	6.58	0.46	2.19	0.12	0.35
osteoclastoma cell line:Hs 706.T	10704-109H2	20.58	3.23	5.00	1.18	0.29	0.88	0.00	0.00
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	15.88	5.61	0.93	0.00	0.00	0.00	0.00	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	27.99	8.06	3.39	1.48	0.42	0.21	0.00	0.00
ovary, adult, pool1	10020-101D2	24.28	4.45	2.97	1.31	0.00	0.26	0.26	0.00
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	18.15	4.03	2.38	1.83	0.37	0.73	0.37	0.18
pancreas, adult, donor1	10049-101G4	16.93	0.94	2.82	0.94	0.00	0.00	0.94	0.00
pancreatic carcinoma cell line:NOR-P1	10698-109G5	23.20	1.96	5.03	1.12	0.84	0.56	0.00	0.56
papillary adenocarcinoma cell line:8505C	10437-106E5	22.66	5.79	7.33	2.56	0.68	1.02	0.17	0.34
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	49.84	5.46	7.12	2.81	0.17	0.66	0.00	0.17
paracentral gyrus, adult, pool1	10035-101E8	26.91	4.12	4.67	6.59	0.46	0.18	0.18	0.27
parietal cortex, adult, donor10258	10373-105G4	24.22	0.73	8.81	11.01	0.00	0.73	0.00	0.00
parietal lobe - adult, donor10196	10171-103B9	22.57	0.94	1.88	5.64	0.00	0.94	0.00	0.00
parietal lobe, adult, donor10252	10157-103A4	19.67	1.71	2.57	4.28	0.00	0.57	0.00	0.29
parietal lobe, adult, pool1	10034-101E7	30.84	3.97	4.32	5.90	0.18	0.62	0.26	0.09
parietal lobe, fetal, donor1	10072-101I9	74.68	6.79	3.88	3.88	0.00	0.00	1.94	0.00
parietal lobe, newborn, donor10223	10356-105E5	21.31	1.87	1.50	7.85	0.00	1.50	0.00	0.00
parotid gland, adult	10199-103F1	17.88	1.85	3.70	1.23	0.00	0.00	0.00	0.00
penis, adult	10200-103F2	25.78	4.30	3.22	2.69	0.00	1.07	0.00	0.00
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	34.21	1.12	5.76	2.42	0.37	0.37	0.00	0.19
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	11.51	2.77	5.39	1.46	0.29	0.15	0.00	0.00
pineal gland - adult, donor10196	10179-103C8	27.09	3.23	1.94	2.58	0.00	0.00	0.00	0.00
pineal gland, adult, donor10252	10160-103A7	45.01	3.55	5.33	4.74	0.59	1.18	0.00	0.00
pineal gland, adult, donor10258	10377-105G8	31.98	3.14	5.02	5.02	0.00	0.00	0.00	0.00
pituitary gland - adult, donor10196	10180-103C9	36.42	2.02	13.15	12.14	0.00	0.00	0.00	0.00
pituitary gland, adult, donor10252	10162-103A9	53.16	8.86	14.59	9.90	0.52	2.61	0.00	0.00
pituitary gland, adult, donor10258	10378-105G9	32.35	0.85	17.02	4.26	0.85	0.85	0.00	0.00
placenta, adult, pool1	10021-101D3	16.77	4.41	4.73	1.29	0.22	0.11	0.11	0.00
plasma cell leukemia cell line:ARH-77	10840-111E3	11.26	10.46	8.74	1.06	0.79	1.19	0.00	0.26
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	35.95	5.76	4.36	1.40	0.78	0.47	0.16	0.16
pons, adult, pool1	10033-101E6	30.12	5.85	4.73	3.79	0.86	0.52	0.26	0.26
postcentral gyrus, adult, pool1	10032-101E5	26.85	4.62	5.14	5.67	0.17	0.44	0.17	0.09
promyelocytes/myelocytes PMC, donor1	12132-128D8	12.55	58.56	6.27	0.00	6.27	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	11.02	11.02	0.00	0.00	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	0.00	11.74	0.00	0.00	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	17.77	6.41	5.83	1.17	0.00	0.29	0.00	0.29
prostate cancer cell line:PC-3	10439-106E7	50.09	23.05	10.16	5.08	1.09	2.00	2.54	1.09
prostate, adult, pool1	10022-101D4	25.48	3.26	3.63	1.63	0.27	0.54	0.00	0.00
putamen, adult, donor10196	10176-103C5	17.70	4.01	4.25	6.37	0.24	0.71	0.47	0.24
putamen, adult, donor10252	10152-102I8	21.57	3.92	0.00	1.96	0.00	0.00	0.00	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	33.88	3.28	5.46	7.65	0.00	0.00	2.19	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	14.74	3.87	6.28	6.04	0.24	0.24	0.00	0.00
putamen, newborn, donor10223	10365-105F5	25.49	1.50	5.25	4.50	0.00	1.50	0.00	0.00
rectal cancer cell line:TT1TKB	10469-106I1	25.60	3.78	11.64	0.58	0.29	1.16	0.00	0.29
rectum, fetal, donor1	10067-101I4	27.82	20.86	6.95	2.78	1.39	1.39	0.00	0.00
renal cell carcinoma cell line:OS-RC-2	10411-106B6	26.92	7.21	6.36	1.70	0.42	0.42	0.21	0.00
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	23.20	0.41	0.00	0.00	0.00	0.00	0.00	0.00
retina, adult, pool1	10030-101E3	33.80	8.75	6.36	2.68	0.20	0.30	0.30	0.30
retinoblastoma cell line:Y79	10475-106I7	26.24	7.01	15.85	2.86	0.52	0.78	0.00	0.00
rhabdomyosarcoma cell line:KYM-1	10787-110H4	18.44	3.69	4.55	1.97	0.00	0.49	0.00	0.00
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	33.18	15.18	1.97	0.84	0.28	0.56	0.56	0.00
sacrococcigeal teratoma cell line:HTST	10695-109G2	9.85	11.37	0.76	0.76	0.00	0.00	0.76	0.00
salivary acinar cells, donor1	11771-123I7	14.57	1.29	5.18	0.65	0.16	0.16	0.00	0.00
salivary acinar cells, donor2	11772-123I8	12.94	0.96	3.86	0.83	0.28	0.41	0.00	0.14
salivary acinar cells, donor3	11773-123I9	23.17	2.65	2.65	0.66	0.00	0.00	0.00	0.00
salivary gland, adult, pool1	10093-102C3	19.45	2.86	1.72	1.72	0.00	0.57	0.00	0.00
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	22.17	2.36	2.61	1.43	0.08	0.25	0.00	0.00
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	16.10	1.53	1.65	0.82	0.00	0.12	0.24	0.00
seminal vesicle, adult	10201-103F3	23.81	5.82	5.29	2.12	0.00	0.00	0.00	0.00
serous adenocarcinoma cell line:JHOS-2	10639-108I9	12.15	2.19	1.94	1.94	0.24	0.73	0.00	0.49
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	15.10	5.79	3.52	1.51	0.00	0.25	0.00	0.00
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	29.10	11.04	4.01	3.01	0.00	3.01	0.00	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	26.73	4.30	5.64	3.90	0.27	1.21	0.00	0.00
signet ring carcinoma cell line:Kato III	10436-106E4	31.83	5.42	14.48	4.31	0.33	1.33	0.11	0.33
signet ring carcinoma cell line:NUGC-4	10483-107A6	13.93	2.06	4.52	1.42	0.65	0.52	0.13	0.39
skeletal muscle - soleus muscle, donor1	10282-104F3	46.11	2.13	8.51	5.67	1.42	0.71	0.71	0.00
skeletal muscle, adult, pool1	10023-101D5	38.26	4.80	14.39	4.80	0.36	0.72	0.24	0.84
skeletal muscle, fetal, donor1	10066-101I3	16.08	4.02	1.01	2.01	1.01	0.00	0.00	0.00
skin, adult, donor1	10074-102A2	13.57	13.57	0.00	0.00	0.00	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	29.04	11.99	3.79	4.42	0.63	0.00	1.89	0.00
small cell cervical cancer cell line:HCSC-1	10800-110I8	26.35	8.67	11.34	3.34	0.00	1.00	1.00	0.00
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	41.29	6.93	8.20	2.84	0.00	0.00	0.63	0.00
small cell lung carcinoma cell line:DMS 144	10841-111E4	34.50	14.46	1.16	0.77	0.00	0.19	2.51	0.00
small cell lung carcinoma cell line:LK-2	10541-107H1	18.13	3.96	10.55	0.49	0.00	0.16	0.16	0.00
small cell lung carcinoma cell line:NCI-H82	10842-111E5	107.13	7.40	13.99	3.54	0.16	0.32	0.48	0.64
small cell lung carcinoma cell line:WA-hT	10562-108A4	29.20	8.72	16.78	5.01	0.65	1.09	0.44	0.22
small intestine, adult, pool1	10024-101D6	42.28	8.96	8.84	4.18	1.79	1.79	0.24	0.36
small intestine, fetal, donor1	10064-101I1	27.27	7.37	3.19	4.18	0.98	1.97	0.25	0.00
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	23.59	5.64	11.80	2.05	0.51	0.51	0.00	0.00
smooth muscle, adult, pool1	10048-101G3	30.76	3.36	2.58	1.55	0.00	0.26	0.52	0.00
somatostatinoma cell line:QGP-1	10781-110G7	27.07	2.41	6.97	2.95	0.54	0.00	0.00	0.54
spinal cord - adult, donor10196	10181-103D1	32.12	2.06	3.67	2.75	0.00	0.00	0.23	0.23
spinal cord, adult, donor10252	10159-103A6	32.33	3.55	1.97	1.18	0.00	0.00	0.39	0.00
spinal cord, adult, donor10258	10369-105F9	30.44	2.08	2.77	3.46	0.00	0.00	0.00	0.00
spinal cord, fetal, donor1	10056-101H2	28.05	5.49	3.05	1.83	0.00	0.00	0.61	0.00
spinal cord, newborn, donor10223	10359-105E8	34.90	1.84	1.84	3.67	0.00	0.00	0.00	0.00
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	12.10	7.17	1.34	1.64	0.15	0.00	0.45	0.00
spleen, adult, pool1	10025-101D7	23.79	8.48	2.20	1.43	0.55	0.00	0.00	0.11
spleen, fetal, pool1	10044-101F8	33.13	18.27	2.62	1.83	1.43	0.24	0.32	0.48
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	31.26	15.11	10.87	4.76	1.55	1.04	0.62	1.24
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	18.04	3.99	8.73	2.47	0.19	0.57	0.00	0.00
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	16.77	4.54	2.45	1.75	0.00	0.35	0.00	0.00
squamous cell carcinoma cell line:T3M-5	10616-108G4	18.76	2.35	2.35	1.56	0.00	1.95	0.00	0.00
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	9.23	1.24	3.71	2.25	0.11	0.56	0.00	0.11
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	11.44	2.12	7.20	0.42	0.00	0.85	0.42	0.00
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	47.81	25.81	15.23	6.35	1.27	2.12	0.85	0.85
stomach, fetal, donor1	10062-101H8	38.45	7.48	5.34	3.20	0.00	3.20	0.00	1.07
submaxillary gland, adult	10202-103F4	23.36	3.42	3.42	1.71	0.00	0.00	0.00	0.57
substantia nigra - adult, donor10196	10178-103C7	0.00	54.27	0.00	0.00	0.00	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	32.40	2.08	1.04	1.45	0.00	0.00	0.00	0.00
substantia nigra, adult, donor10258	10371-105G2	18.62	3.62	3.62	5.69	0.52	0.00	0.00	0.00
substantia nigra, newborn, donor10223	10358-105E7	33.21	2.83	0.00	0.71	0.00	0.00	0.00	0.71
synovial sarcoma cell line:HS-SY-II	10441-106E9	30.49	20.86	10.55	2.52	1.83	0.46	0.46	0.23
temporal lobe, adult, pool1	10031-101E4	30.01	4.32	5.26	6.44	0.34	0.76	0.08	0.17
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	36.33	4.99	7.12	7.12	0.00	0.00	0.00	0.00
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	39.12	8.79	6.59	7.47	0.00	0.88	0.44	0.00
tenocyte, donor1	11763-123H8	9.43	4.54	0.35	1.05	0.35	0.00	0.00	0.35
tenocyte, donor2	11765-123I1	9.92	2.29	0.38	1.14	0.00	0.00	0.00	0.00
tenocyte, donor3	11768-123I4	7.41	4.82	0.00	1.11	0.74	0.00	0.00	0.00
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	59.49	25.49	17.34	8.16	1.53	2.55	2.21	1.19
teratocarcinoma cell line:NCR-G1	10798-110I6	27.44	5.70	4.62	1.70	0.15	1.08	0.31	0.31
teratocarcinoma cell line:PA-1	10807-111A6	32.86	16.43	7.44	5.58	1.39	3.41	3.25	0.31
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	17.77	1.40	3.17	2.03	0.38	0.63	0.13	0.13
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	60.13	3.78	12.10	3.03	0.00	0.00	0.38	0.00
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	48.42	6.65	6.33	4.36	0.11	0.44	0.22	0.11
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	16.29	1.30	5.21	2.28	0.00	0.00	0.33	0.00
testis, adult, pool1	10026-101D8	19.76	2.36	3.54	1.61	0.11	0.32	0.00	0.21
testis, adult, pool2	10096-102C6	13.53	3.16	8.12	1.80	0.45	0.00	0.90	0.45
thalamus - adult, donor10196	10168-103B6	33.12	2.21	2.21	2.21	1.10	1.10	0.00	0.00
thalamus, adult, donor10252	10154-103A1	35.48	3.91	1.72	2.50	0.16	0.16	0.31	0.00
thalamus, adult, donor10258, tech_rep1	10370-105G1	30.79	1.54	7.70	9.24	0.00	1.54	0.00	1.54
thalamus, adult, donor10258, tech_rep2	10370-105G1	24.04	2.47	2.31	1.32	0.16	0.33	0.16	0.33
thalamus, newborn, donor10223	10366-105F6	16.68	0.58	2.30	2.30	0.58	1.15	0.00	0.58
throat, adult	10209-103G2	26.96	8.49	9.99	3.99	0.25	1.25	0.25	0.25
throat, fetal, donor1	10061-101H7	26.51	8.23	6.09	2.74	0.61	0.00	0.00	0.00
thymic carcinoma cell line:Ty-82	10803-111A2	29.81	4.37	8.35	2.78	0.40	0.00	0.00	0.20
thymus, adult, pool1	10027-101D9	28.04	36.78	17.00	4.27	3.78	0.89	1.19	0.60
thymus, fetal, pool1	10043-101F7	34.60	45.30	16.94	4.36	4.36	0.83	1.87	0.94
thyroid carcinoma cell line:KHM-5M	10776-110G2	9.17	3.59	2.93	1.06	0.00	0.27	0.00	0.00
thyroid carcinoma cell line:TCO-1	10783-110G9	23.89	6.98	3.07	2.10	0.42	0.00	0.28	0.42
thyroid, adult, pool1	10028-101E1	31.73	5.51	8.30	3.83	0.19	0.65	0.00	0.19
thyroid, fetal, donor1	10060-101H6	26.10	6.06	3.43	6.06	0.79	0.53	0.79	0.26
tongue epidermis (fungiform papillae), donor1	10288-104F9	24.64	3.08	3.08	6.16	0.00	0.00	0.00	0.00
tongue, adult	10203-103F5	26.28	4.65	5.81	4.42	0.47	2.33	0.93	0.00
tongue, fetal, donor1	10059-101H5	20.10	7.88	3.15	3.55	0.00	1.58	0.79	0.00
tonsil, adult, pool1	10047-101G2	30.45	21.04	13.12	2.80	1.50	1.20	0.20	0.10
trachea, adult, pool1	10029-101E2	22.58	4.99	2.78	1.55	0.41	0.33	0.16	0.00
trachea, fetal, donor1	10058-101H4	22.70	5.00	4.62	2.31	0.38	0.38	0.77	0.00
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	8.15	7.44	2.13	1.06	0.00	0.35	0.00	0.00
transitional-cell carcinoma cell line:5637	10418-106C4	23.71	10.13	12.06	3.24	1.01	0.61	0.10	0.10
transitional-cell carcinoma cell line:JMSU1	10492-107B6	36.04	3.76	3.60	2.82	0.16	0.31	0.16	0.00
tridermal teratoma cell line:HGRT	10694-109G1	9.51	9.51	0.00	1.90	0.00	0.00	0.00	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	13.46	2.62	4.23	1.27	0.08	0.42	0.42	0.00
umbilical cord, fetal, donor1	10057-101H3	8.35	4.17	0.00	0.00	0.00	0.00	0.00	0.00
uterus, adult, pool1	10100-102D1	40.78	6.31	2.05	2.39	0.17	0.17	0.17	0.00
uterus, fetal, donor1	10055-101H1	22.01	11.77	1.02	1.02	0.00	0.00	0.00	0.00
vagina, adult	10204-103F6	22.62	3.88	1.29	1.29	0.00	0.65	0.00	0.00
vein, adult	10191-103E2	16.00	15.78	4.60	1.75	1.10	0.22	0.00	0.22
xeroderma pigentosum b cell line:XPL 17	10563-108A5	10.15	11.75	5.07	1.87	1.34	0.53	0.00	0.00